TW201024414A - Nucleic acid for use in algae and use thereof - Google Patents
Nucleic acid for use in algae and use thereof Download PDFInfo
- Publication number
- TW201024414A TW201024414A TW97151401A TW97151401A TW201024414A TW 201024414 A TW201024414 A TW 201024414A TW 97151401 A TW97151401 A TW 97151401A TW 97151401 A TW97151401 A TW 97151401A TW 201024414 A TW201024414 A TW 201024414A
- Authority
- TW
- Taiwan
- Prior art keywords
- algae
- gene
- protein
- composition
- exogenous gene
- Prior art date
Links
- 241000195493 Cryptophyta Species 0.000 title claims abstract description 101
- 108020004707 nucleic acids Proteins 0.000 title claims abstract description 13
- 102000039446 nucleic acids Human genes 0.000 title claims abstract description 13
- 150000007523 nucleic acids Chemical class 0.000 title claims abstract description 13
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 131
- 238000000034 method Methods 0.000 claims abstract description 25
- 239000000203 mixture Substances 0.000 claims abstract description 21
- 102000004190 Enzymes Human genes 0.000 claims abstract description 13
- 108090000790 Enzymes Proteins 0.000 claims abstract description 13
- 210000002421 cell wall Anatomy 0.000 claims abstract description 9
- 239000002773 nucleotide Substances 0.000 claims abstract description 4
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 4
- 230000009261 transgenic effect Effects 0.000 claims description 40
- 235000018102 proteins Nutrition 0.000 claims description 32
- 102000004169 proteins and genes Human genes 0.000 claims description 32
- 241000195649 Chlorella <Chlorellales> Species 0.000 claims description 29
- 238000012546 transfer Methods 0.000 claims description 25
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 22
- 102000035195 Peptidases Human genes 0.000 claims description 21
- 108091005804 Peptidases Proteins 0.000 claims description 21
- 230000012010 growth Effects 0.000 claims description 20
- 241000700605 Viruses Species 0.000 claims description 19
- 241000196324 Embryophyta Species 0.000 claims description 18
- 210000004051 gastric juice Anatomy 0.000 claims description 18
- 241000251468 Actinopterygii Species 0.000 claims description 14
- 101000798100 Bos taurus Lactotransferrin Proteins 0.000 claims description 14
- 108090000284 Pepsin A Proteins 0.000 claims description 14
- 229940072440 bovine lactoferrin Drugs 0.000 claims description 14
- 108020001507 fusion proteins Proteins 0.000 claims description 14
- 102000037865 fusion proteins Human genes 0.000 claims description 13
- 230000004071 biological effect Effects 0.000 claims description 12
- 238000004520 electroporation Methods 0.000 claims description 12
- 229940088598 enzyme Drugs 0.000 claims description 12
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 12
- 241000894006 Bacteria Species 0.000 claims description 11
- 230000000844 anti-bacterial effect Effects 0.000 claims description 11
- 229940066716 pepsin a Drugs 0.000 claims description 11
- 108010051696 Growth Hormone Proteins 0.000 claims description 10
- 241000192701 Microcystis Species 0.000 claims description 10
- 102100039652 Pepsin A-5 Human genes 0.000 claims description 10
- 210000004027 cell Anatomy 0.000 claims description 10
- 239000013505 freshwater Substances 0.000 claims description 10
- 239000000122 growth hormone Substances 0.000 claims description 10
- 241000611184 Amphora Species 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 8
- 108010054624 red fluorescent protein Proteins 0.000 claims description 8
- 240000002900 Arthrospira platensis Species 0.000 claims description 7
- 235000016425 Arthrospira platensis Nutrition 0.000 claims description 7
- 241000199914 Dinophyceae Species 0.000 claims description 7
- 102000018697 Membrane Proteins Human genes 0.000 claims description 7
- 108010052285 Membrane Proteins Proteins 0.000 claims description 7
- 241001491691 Thalassiosira Species 0.000 claims description 7
- 238000002309 gasification Methods 0.000 claims description 7
- 241000894007 species Species 0.000 claims description 7
- 229940082787 spirulina Drugs 0.000 claims description 7
- 244000025254 Cannabis sativa Species 0.000 claims description 6
- 241000233866 Fungi Species 0.000 claims description 6
- 241001465754 Metazoa Species 0.000 claims description 6
- 241000180701 Nitzschia <flatworm> Species 0.000 claims description 6
- 241000206731 Phaeodactylum Species 0.000 claims description 6
- 241000607626 Vibrio cholerae Species 0.000 claims description 6
- 230000000840 anti-viral effect Effects 0.000 claims description 6
- 230000007613 environmental effect Effects 0.000 claims description 6
- 230000001965 increasing effect Effects 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 6
- 229940118696 vibrio cholerae Drugs 0.000 claims description 6
- 241000195585 Chlamydomonas Species 0.000 claims description 5
- 241001501885 Isochrysis Species 0.000 claims description 5
- 241000195615 Volvox Species 0.000 claims description 5
- 241001222097 Xenocypris argentea Species 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 5
- 235000012162 pavlova Nutrition 0.000 claims description 5
- 241000238557 Decapoda Species 0.000 claims description 4
- 102000057297 Pepsin A Human genes 0.000 claims description 4
- 241000318927 Shrimp white spot syndrome virus Species 0.000 claims description 4
- 239000003550 marker Substances 0.000 claims description 4
- 229940111202 pepsin Drugs 0.000 claims description 4
- 238000012216 screening Methods 0.000 claims description 4
- 241000237858 Gastropoda Species 0.000 claims description 3
- 108010063045 Lactoferrin Proteins 0.000 claims description 3
- 241000196305 Nannochloris Species 0.000 claims description 3
- 241000224474 Nannochloropsis Species 0.000 claims description 3
- 241000192497 Oscillatoria Species 0.000 claims description 3
- 108091006047 fluorescent proteins Proteins 0.000 claims description 3
- 102000034287 fluorescent proteins Human genes 0.000 claims description 3
- 238000005286 illumination Methods 0.000 claims description 3
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 claims description 3
- 241000159660 Nannochloropsis oculata Species 0.000 claims description 2
- 206010036790 Productive cough Diseases 0.000 claims description 2
- 241000206733 Skeletonema Species 0.000 claims description 2
- 241000196321 Tetraselmis Species 0.000 claims description 2
- 230000002238 attenuated effect Effects 0.000 claims description 2
- 230000015572 biosynthetic process Effects 0.000 claims description 2
- 239000000835 fiber Substances 0.000 claims description 2
- 229940078795 lactoferrin Drugs 0.000 claims description 2
- 235000021242 lactoferrin Nutrition 0.000 claims description 2
- 239000003973 paint Substances 0.000 claims description 2
- 210000003802 sputum Anatomy 0.000 claims description 2
- 208000024794 sputum Diseases 0.000 claims description 2
- 238000003786 synthesis reaction Methods 0.000 claims description 2
- 102000018997 Growth Hormone Human genes 0.000 claims 3
- 241000195628 Chlorophyta Species 0.000 claims 2
- 241000502321 Navicula Species 0.000 claims 2
- 241001038158 Pavlovaceae Species 0.000 claims 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims 2
- 241000239226 Scorpiones Species 0.000 claims 2
- 230000001580 bacterial effect Effects 0.000 claims 2
- 108010021843 fluorescent protein 583 Proteins 0.000 claims 2
- 241000195634 Dunaliella Species 0.000 claims 1
- 206010061218 Inflammation Diseases 0.000 claims 1
- 102000010445 Lactoferrin Human genes 0.000 claims 1
- 241000530454 Litopenaeus schmitti Species 0.000 claims 1
- 108010047357 Luminescent Proteins Proteins 0.000 claims 1
- 102000006830 Luminescent Proteins Human genes 0.000 claims 1
- 241000209504 Poaceae Species 0.000 claims 1
- 102000029797 Prion Human genes 0.000 claims 1
- 108091000054 Prion Proteins 0.000 claims 1
- 241000219492 Quercus Species 0.000 claims 1
- 241000270666 Testudines Species 0.000 claims 1
- 238000003776 cleavage reaction Methods 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 210000003746 feather Anatomy 0.000 claims 1
- 230000002496 gastric effect Effects 0.000 claims 1
- 230000004054 inflammatory process Effects 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 229910052754 neon Inorganic materials 0.000 claims 1
- GKAOGPIIYCISHV-UHFFFAOYSA-N neon atom Chemical compound [Ne] GKAOGPIIYCISHV-UHFFFAOYSA-N 0.000 claims 1
- 239000001103 potassium chloride Substances 0.000 claims 1
- 235000011164 potassium chloride Nutrition 0.000 claims 1
- 230000007017 scission Effects 0.000 claims 1
- 241000701447 unidentified baculovirus Species 0.000 claims 1
- 210000004885 white matter Anatomy 0.000 claims 1
- 241000283690 Bos taurus Species 0.000 abstract description 4
- 101800004361 Lactoferricin-B Proteins 0.000 abstract description 2
- CFFMZOZGXDAXHP-HOKBLYKWSA-N lactoferricin Chemical compound C([C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]1CSSC[C@@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CO)C(=O)N[C@H](C(N[C@H](C(=O)N1)[C@@H](C)O)=O)[C@@H](C)CC)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CFFMZOZGXDAXHP-HOKBLYKWSA-N 0.000 abstract description 2
- 108020004414 DNA Proteins 0.000 description 19
- 239000000047 product Substances 0.000 description 17
- 239000000243 solution Substances 0.000 description 17
- 238000011282 treatment Methods 0.000 description 12
- 240000009108 Chlorella vulgaris Species 0.000 description 9
- 235000007089 Chlorella vulgaris Nutrition 0.000 description 9
- 238000002474 experimental method Methods 0.000 description 9
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 8
- 208000015181 infectious disease Diseases 0.000 description 8
- 102100038803 Somatotropin Human genes 0.000 description 7
- 230000003321 amplification Effects 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- 239000002299 complementary DNA Substances 0.000 description 7
- 238000003199 nucleic acid amplification method Methods 0.000 description 7
- 210000002706 plastid Anatomy 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
- 238000002347 injection Methods 0.000 description 6
- 239000007924 injection Substances 0.000 description 6
- 239000006228 supernatant Substances 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 241000254032 Acrididae Species 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 238000001962 electrophoresis Methods 0.000 description 5
- 239000013642 negative control Substances 0.000 description 5
- 239000013641 positive control Substances 0.000 description 5
- 239000013535 sea water Substances 0.000 description 5
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- 241000233614 Phytophthora Species 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 239000001569 carbon dioxide Substances 0.000 description 4
- 229910002092 carbon dioxide Inorganic materials 0.000 description 4
- 210000000349 chromosome Anatomy 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- 235000020183 skimmed milk Nutrition 0.000 description 4
- 239000013598 vector Substances 0.000 description 4
- 101150028074 2 gene Proteins 0.000 description 3
- 238000007400 DNA extraction Methods 0.000 description 3
- 101100018009 Drosophila melanogaster Hsp70Aa gene Proteins 0.000 description 3
- 101100507660 Drosophila melanogaster Hsp70Ab gene Proteins 0.000 description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 102100034343 Integrase Human genes 0.000 description 3
- 102000004020 Oxygenases Human genes 0.000 description 3
- 108090000417 Oxygenases Proteins 0.000 description 3
- 241000206766 Pavlova Species 0.000 description 3
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 3
- 102000006382 Ribonucleases Human genes 0.000 description 3
- 108010083644 Ribonucleases Proteins 0.000 description 3
- 239000006180 TBST buffer Substances 0.000 description 3
- 239000007983 Tris buffer Substances 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000014509 gene expression Effects 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 239000011259 mixed solution Substances 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 238000000751 protein extraction Methods 0.000 description 3
- 230000035939 shock Effects 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 230000004083 survival effect Effects 0.000 description 3
- 238000013518 transcription Methods 0.000 description 3
- 230000035897 transcription Effects 0.000 description 3
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 3
- 229960005486 vaccine Drugs 0.000 description 3
- 238000001262 western blot Methods 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- 108020004463 18S ribosomal RNA Proteins 0.000 description 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 2
- 239000002028 Biomass Substances 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 108091026890 Coding region Proteins 0.000 description 2
- 108020004705 Codon Proteins 0.000 description 2
- 108020004635 Complementary DNA Proteins 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 102100032241 Lactotransferrin Human genes 0.000 description 2
- 240000007472 Leucaena leucocephala Species 0.000 description 2
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 239000000020 Nitrocellulose Substances 0.000 description 2
- 241000700141 Rotifera Species 0.000 description 2
- 241000270708 Testudinidae Species 0.000 description 2
- 229960000723 ampicillin Drugs 0.000 description 2
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 238000010804 cDNA synthesis Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- UQLDLKMNUJERMK-UHFFFAOYSA-L di(octadecanoyloxy)lead Chemical compound [Pb+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O UQLDLKMNUJERMK-UHFFFAOYSA-L 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000010494 dissociation reaction Methods 0.000 description 2
- 230000005593 dissociations Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 239000013604 expression vector Substances 0.000 description 2
- 239000011536 extraction buffer Substances 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 229920001220 nitrocellulos Polymers 0.000 description 2
- 229940126578 oral vaccine Drugs 0.000 description 2
- 238000003752 polymerase chain reaction Methods 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000010839 reverse transcription Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 230000005945 translocation Effects 0.000 description 2
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 2
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- 241000269814 Acanthopagrus latus Species 0.000 description 1
- 102000044503 Antimicrobial Peptides Human genes 0.000 description 1
- 108700042778 Antimicrobial Peptides Proteins 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- 101100178679 Caenorhabditis elegans hsp-1 gene Proteins 0.000 description 1
- 244000132059 Carica parviflora Species 0.000 description 1
- 235000014653 Carica parviflora Nutrition 0.000 description 1
- 108010059892 Cellulase Proteins 0.000 description 1
- 241000238366 Cephalopoda Species 0.000 description 1
- 241000195651 Chlorella sp. Species 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 229910021580 Cobalt(II) chloride Inorganic materials 0.000 description 1
- 244000301850 Cupressus sempervirens Species 0.000 description 1
- 241000192700 Cyanobacteria Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- ZAQJHHRNXZUBTE-NQXXGFSBSA-N D-ribulose Chemical compound OC[C@@H](O)[C@@H](O)C(=O)CO ZAQJHHRNXZUBTE-NQXXGFSBSA-N 0.000 description 1
- ZAQJHHRNXZUBTE-UHFFFAOYSA-N D-threo-2-Pentulose Natural products OCC(O)C(O)C(=O)CO ZAQJHHRNXZUBTE-UHFFFAOYSA-N 0.000 description 1
- 102000007260 Deoxyribonuclease I Human genes 0.000 description 1
- 108010008532 Deoxyribonuclease I Proteins 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 241000305071 Enterobacterales Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000224472 Eustigmatophyceae Species 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 102000002812 Heat-Shock Proteins Human genes 0.000 description 1
- 108010004889 Heat-Shock Proteins Proteins 0.000 description 1
- 241000251511 Holothuroidea Species 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 1
- 241000772413 Lutrogale perspicillata Species 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 229910021380 Manganese Chloride Inorganic materials 0.000 description 1
- GLFNIEUTAYBVOC-UHFFFAOYSA-L Manganese chloride Chemical compound Cl[Mn]Cl GLFNIEUTAYBVOC-UHFFFAOYSA-L 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 206010027982 Morphoea Diseases 0.000 description 1
- 241001502127 Mullus barbatus Species 0.000 description 1
- POCMJUGHYNQZCL-UHFFFAOYSA-N OCCS.OS(O)(=O)=O Chemical compound OCCS.OS(O)(=O)=O POCMJUGHYNQZCL-UHFFFAOYSA-N 0.000 description 1
- 241000241034 Palaemon pugio Species 0.000 description 1
- 235000009388 Parthenocissus quinquefolia Nutrition 0.000 description 1
- 241000219099 Parthenocissus quinquefolia Species 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 101710180012 Protease 7 Proteins 0.000 description 1
- 241000589774 Pseudomonas sp. Species 0.000 description 1
- 101150111829 RBCS2 gene Proteins 0.000 description 1
- 239000012162 RNA isolation reagent Substances 0.000 description 1
- 241000316848 Rhodococcus <scale insect> Species 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241001521797 Scorpaena notata Species 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 108700019146 Transgenes Proteins 0.000 description 1
- 241000218989 Trichosanthes Species 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 238000009360 aquaculture Methods 0.000 description 1
- 244000144974 aquaculture Species 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 239000007975 buffered saline Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 229940106157 cellulase Drugs 0.000 description 1
- 238000005660 chlorination reaction Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- GVPFVAHMJGGAJG-UHFFFAOYSA-L cobalt dichloride Chemical compound [Cl-].[Cl-].[Co+2] GVPFVAHMJGGAJG-UHFFFAOYSA-L 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 229910000365 copper sulfate Inorganic materials 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 229910000366 copper(II) sulfate Inorganic materials 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 210000003495 flagella Anatomy 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 238000012252 genetic analysis Methods 0.000 description 1
- 239000005431 greenhouse gas Substances 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 238000011419 induction treatment Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 238000010841 mRNA extraction Methods 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 239000011565 manganese chloride Substances 0.000 description 1
- 235000002867 manganese chloride Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 239000011325 microbead Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 238000009377 nuclear transmutation Methods 0.000 description 1
- 210000004940 nucleus Anatomy 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- NIXKBAZVOQAHGC-UHFFFAOYSA-N phenylmethanesulfonic acid Chemical compound OS(=O)(=O)CC1=CC=CC=C1 NIXKBAZVOQAHGC-UHFFFAOYSA-N 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- -1 polypropylene Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 230000004481 post-translational protein modification Effects 0.000 description 1
- 230000001124 posttranscriptional effect Effects 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 229910000105 potassium hydride Inorganic materials 0.000 description 1
- NTTOTNSKUYCDAV-UHFFFAOYSA-N potassium hydride Chemical compound [KH] NTTOTNSKUYCDAV-UHFFFAOYSA-N 0.000 description 1
- OTYBMLCTZGSZBG-UHFFFAOYSA-L potassium sulfate Chemical compound [K+].[K+].[O-]S([O-])(=O)=O OTYBMLCTZGSZBG-UHFFFAOYSA-L 0.000 description 1
- 229910052939 potassium sulfate Inorganic materials 0.000 description 1
- 239000001120 potassium sulphate Substances 0.000 description 1
- 235000011151 potassium sulphates Nutrition 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000004952 protein activity Effects 0.000 description 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
- 210000001938 protoplast Anatomy 0.000 description 1
- 108700022487 rRNA Genes Proteins 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 239000012146 running buffer Substances 0.000 description 1
- 239000012723 sample buffer Substances 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 239000011684 sodium molybdate Substances 0.000 description 1
- 235000015393 sodium molybdate Nutrition 0.000 description 1
- TVXXNOYZHKPKGW-UHFFFAOYSA-N sodium molybdate (anhydrous) Chemical compound [Na+].[Na+].[O-][Mo]([O-])(=O)=O TVXXNOYZHKPKGW-UHFFFAOYSA-N 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- 235000011178 triphosphate Nutrition 0.000 description 1
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
- RZLVQBNCHSJZPX-UHFFFAOYSA-L zinc sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Zn+2].[O-]S([O-])(=O)=O RZLVQBNCHSJZPX-UHFFFAOYSA-L 0.000 description 1
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
201024414 九、發明說明: 【發明所屬之技術領域】 本發明係關於一種可在藻類中轉譯出牛乳鐵蛋白(LFB)之核酸,及 將其導入藻類之基因轉殖技術及其相關用途。 【先前技術】 擬球藻是一種無性生殖的海水微藻,在分類學上屬於金藻門 φ (Chrysophycophyta)、萁版點薄綱(Eustigmatophyceae)、真敗點 漆 U iEustigmatales)、翠珠J秦科 QMonodopsidaceae)、擬珠蘇愚 ’為一圓球型之真核單細胞藻類。其直徑為2 到4x106公尺、無鞭毛(flagellum)、無眼點(eyesp〇t),具有堅韌 的細胞壁與相當厚的細胞外構造,外觀與綠球藻(C/2/ore//a vw/gar^ 極為相似’故稱之為擬球藻’是魚瑕貝類的天然销;料之一。由於其 具有增殖速度快、培養成本低等優勢,目前被廣泛使用在台灣的海 參 水種苗與僻料生物輪蟲的生產。此外’由於擬球藻含有高量的不飽 和脂肪酸(eicosapentaenoic acid,EPA )( Apt Κ. Ε.及Behrens P. W. 1999 Commercial developments in microalgal biotechnology. J Phycol 35: 215-226),也能作為食品添加物或健康食品,具有高度的經濟 價值。 由於擬球藻疋真核生物,因此它不僅能像細菌般快速生長,還能進 行細菌等原核生物無法做到的轉錄與轉譯後修飾(Lin cereghin〇 201024414 G.P.L.及 Gregg J.M. 1999 Applications of yeast in biotechnology: protein production and genetic analysis. Curr Opin Biotechnol 10: 422-427 ; Swartz J.R. 2001 Advances in Escherichia coli production of therapeutic proteins.. Curr Opin Biotechnol. 12: 195-201 ),這使得擬 球藻能夠生產許多原核系統生物反應器所不能製造的複雜蛋白質。 與陸生植物相比,由於陸生植物的生長週期多半長達一至兩年,從 轉殖株篩選到種子數量足以進行大規模生產往往需耗時三年以上。 但擬球藻在環境適合的情況下能在幾小時内就能完成其生長週期, 可大幅縮短轉殖珠篩選與放大所需的時間。除了生長快速之外,由 於擬球藻不產生配子’不會像陸生植物般因為花粉的傳播,而使得 野生種被基因改造物種的配子所污染,進而造成生態問題。且由於 擬球藻是海水物種’其生產過程不會如陸生植物般耗用大量的淡水 與可耕地’因此更有利於商業化的進行。 【發明内容】 ❿ 擬球藻疋一種非常有潛力的生物反應器,且擬球藻的藻種冷康保種 技術也已完成(P〇ncet j.M,Ver〇n B 2〇〇3 Cry〇preseryati〇n 〇f the unicellular marine alga, Nannochloropsis oculata, Biotechnol Lett. 25: 2017-2022)。因此若能將擬球藻以基因轉殖技術改造成生物反應 器,將可使擬球藻成為非常有應用價值的生物材料生產平台。 本發明即是以擬球藻為對象,透過基因轉殖技術使其具有能生產功 201024414 能性蛋白之能力,而解決目前生物反應器時常遇到的高使用成本 (例如.細胞培養)與南時間成本(例如:陸生植物生物反應器) 兩大問題。本發明之生物反應器運作時還能吸收二氧化碳,不需耗 用有限的淡水與可耕地,且能以口服投餵方式直接將產物送於魚蝦 貝體内,能大幅降低水產疫苗、抗菌蛋白與生長激素的生產與使用 成本,成為一低成本且兼具環保與二氧化碳減量功能之生物反應 器。 此外,由於擬球藻能產生糖類及脂肪,可作為生質酒精與生質柴油 之原料,本發明能運用於提升擬球藻之生質能源生產效率,故本發 明之生物反應器另可應用於生質能源之開發;而由於擬球藻生長過 程會吸附大量二氧化碳,本發明能運用於提升擬球藻之二氧化碳吸 附效率,有助於溫室氣體之減量;再者,擬球藻是目前水產養殖業 常用之餌料生物,本發明可用來生產水產口服抗菌蛋白、口服疫苗 參 與口 服生長激素等’能發揮降低水產養殖成本與提升產業競爭力。 本發明將三種不同的外源性基因轉殖到擬球藻,此三種基因為促進 魚類生長的黃鰭鯛生長激素(rGH)、可代替抗生素的融合蛋白【紅 螢光(DsRed)與牛乳鐵蛋白(Bovine lactoferricin,LFB)】及可作 為疫苗的草瑕白點病病毒之表面膜蛋白(VP28),過 蛋白質與生物活性試驗的檢測後,能清楚的顯示本發明能成功的完 成擬球藻基因轉殖,使擬球藻生產這三種來源、特性與功能都不相 201024414 同的外源性蛋白,且這些由擬_生產的外·蛋㈣樣具有 活性。 是以’本發明提供一種可在蕩類中表現之核酸,其係由編碼seqid NO : 3所示之核魏序列所組成,其中該核_可於轴中轉譯出 牛乳鐵蛋白(LFB)。 • 在本發明之較佳實關中,該滅另可與編碼螢光蛋自之序列做操 作生連接,轉譯出牛乳鐵蛋白與螢光蛋白的融合蛋白其中勞光蛋 ㈣作為轉祕之標記(seleetablemai>ke〇,會錢功轉殖之藻株 中發出螢光。傳絲因轉殖常以抗生素抗性作觸選標記,以區別 轉殖與非轉殖細胞,但使用抗抗生素基因可能會帶來食用安全性和 生態破壞的疑慮。本發明以螢光作為篩選標記,對於食用方面和環 境影響是不具危險性的。 ® 在本發明之更佳實施例中,該核酸另可與編碼紅榮光蛋白⑽以⑴ 之序列做操雜雜,產生包含編碼如SEQ①NO : 2所示之核苦 酸序列’該序列可轉譯出牛乳鐵蛋白與紅螢光蛋白的融合蛋白 (LFB-DsRed),其中LFB與DsRed接合處包含一胃蛋白酶裁切位 置。 在本發明之最佳實施例中,該核酸另可操作性連接上一啟動子,其 中該啟動子係編碼如SEqIDN〇 :丨所示之核苷酸序列。 201024414 本發明之較佳實施例中,該藻類係單細胞藻類。 本發明之更佳實施例中,該藻類係係選自海洋或淡水的綠藻 (Chlorella)、翠胞巍(Chlamydomonas')、風蘇 iVolvox)、龟斜豫 i Cheatocerois )、三龟揭指焦 Q Phaeodactylum )、貴儀蘇 (Skeletonema)、羽狀ί夕蘇(JVavicula)、菱_形蘇(Nitzschia)、海缝 漆(Thalassiosira) ' 雙层蘇(^Amphora)、微綠球f秦 CNannochloris)、 敎珠儀 iNannochloropsis)、烏· iTetraselmis)、故氏§XDunaliella)、 場旋臻(Spirulina)、’敫跑^ (Microcystis)、Μ臻慝(〇scuiatoria)、 等鞭金藻(/soc/7〇w;y )、巴夫藻(i^v/ονα ) '或橫裂假藻 {Dinophyceae)。 本發明之最佳實施例中,該藻類係擬球藻。 本發明又提供一種在藻類中產生外源性基因產物的方法,其包含步 驟如下:a.使用蛋白分解酵素液削弱或移除藻類細胞壁,使其適合 進行基因轉殖;b.將編碼外源性基因產物之基因轉殖入藻類中;及 c.表現外源性基因得到外源性基因產物。 201024414 本發明之用語『外源性基因』係指非實驗藻類本身所擁有的基因, 其來源可為細菌、真菌、病毒、植物或動物。本發明之最佳實施例 中,該外源性基因係包含牛乳鐵蛋白與紅螢光蛋白的融合蛋白 (LFB-DsRed)基因、草蝦白點病病毒表面蛋白(vp28)基因、或 黃鰭鯛生長激素(rYGH)基因。 本發明之較佳實施例中,轉殖後的外源性基因產物具有包含抗菌、抗 • 病毒 '或增加生長速率等之生物活性;本發明之最佳實施例中,該生 物活性係包含可抗腸炎弧菌(細·⑽)、可抗白點病 病毒(white spot syndrome baculovirus)、或可增加生長速率2到3倍。 本發明之用語『蛋白分解酵素』係指可分解蛋白質的酵素,並無來 源限制,包括自然(野生型)的蛋白分解酵素,以及其任何具有酵 素活性的突變形(mutants)、變異型(variants)、或片段(fragments) 等等’亦包含如合成蛋白酶之重組蛋白酵素。 本發明中之『蛋白分解酵素』包括但不限於胃蛋白酶A。 本發明之用語『蛋白分解酵素液』係指包含蛋白分解酵素及可活化該 酵素之環境溶液的混合溶液。在本發明之較佳實施例中,該蛋白分解 酵素液係包含鹽酸、氣化鉀、及胃蛋白酶A的合成胃液;在本發明 之最佳實施例中,該合成胃液係包含15〇mM鹽酸、151111^氣化鉀、 201024414 及5%胃蛋白酶A。 傳統電穿孔轉殖法係使用纖維素酶處理酵母菌細胞壁以進行電穿孔 轉殖,但用於藻類卻效果不彰。本發明利用蛋白分解酵素,可有效率 地削弱或移除藻類細胞壁,使其適合進行基因轉殖。 本發明之較佳實施例中,該藻類係以沒2培養基,培養於光源為白色 Φ 日光燈的2<7°C恆溫培養箱,並提供10小時光照及14小時黑暗的光 照週期。 本發明之較佳實施例中’係使用電穿孔轉殖法將編碼外源性基因產物 之基因轉殖入藻類中;電穿孔轉殖條件係包含電壓值2000 v/mm、 脈衝時間20微秒、及脈衝次數1〇次。 Φ 本發明之較佳實施例中,該藻類係單細胞藻類。 本發明之更佳實施例中,該藻類係係選自海洋或淡水的綠藻 (Chiorelh)、單胞議(Chlamydomonas)、風議;(Volvox)、苒 M f条 (Cheatoceros )、三龟褐指藻(phaeodactylum )、骨條蘇 (Ske〖etonema)、羽狀矽藻(Navicuh)、菱形藻(Nitzschia)、海鏠 薄;{Thalassiosira) ' 雙塔無(_Amphora)、敬綠珠落 QNarmochloris)、 201024414 擬來臻(Namochbmpsis)、烏薄 QTetraselmis)、故氏臻(DunalieUa)、 螺、旋臻(Spirulina)、樹Jt臻(Microcystis)、氣臻魇 Q〇scuiat〇ria)、 等鞭金藻(Zsoc/i〇^ )、巴夫藻(尸αν/ονα )、或橫裂假藻 (Dinophyceae) 0 本發明之最佳實施例中,該藻類係擬球藻。 春 本發明更提供一種基因轉殖藻類’其細胞壁係使用蛋白分解酵素液來 削弱或移除。在本發明之較佳實施例中,該蛋白分解酵素液係包含鹽 酸、氣化鉀、及胃蛋白酶A的合成胃液;在本發明之最佳實施例中, 該合成胃液係包含150 mM鹽酸、15 mM氯化卸、及5%胃蛋白酶A。 本發明之較佳實施例中,該藻類包含編碼外源性基因產物之轉殖基 因;其中該外源性基因係來自細菌、真菌、病毒、植物或動物。 本發明之最佳實施例中’該外源性基因係包含牛乳鐵蛋白與紅螢光蛋 白的融合蛋白(LFB-DsRed)基因、草蝦白點病病毒表面蛋白(VP28) 基因、或黃鰭鯛生長激素(rYGH)基因。 本發明之較佳實施例中,該外源性基因產物可在藻類中表現並具有包 含抗菌、抗病毒、或增加生長速率等之生物活性;本發明之最佳實施 例中’該生物活性係包含可抗腸炎孤菌(⑽)、 12 201024414 可抗白點病病毒(white spot syndrome baculovirus)、或可增加生長速 率2到3倍。 本發明之較佳實施例中,該藻類係單細胞藻類。201024414 IX. Description of the Invention: [Technical Field of the Invention] The present invention relates to a nucleic acid-transfer technology capable of translating bovine lactoferrin (LFB) in algae and introducing it into algae and related uses. [Prior Art] Chlorella is a kind of asexually reproduced seawater microalgae, which belongs to the classification of Chrysophycophyta, Eustigmatophyceae, UiEustigmatales, and Cuizhu J. Qin (QMonodopsidaceae), Zhuozhu Suyu' is a spherical type of eukaryotic unicellular algae. It has a diameter of 2 to 4x106 meters, flagellum, no eye points (eyesp〇t), has a tough cell wall and a fairly thick extracellular structure, and looks with Chlorella (C/2/ore//a) Vw/gar^ is very similar, so it is called natural fish. It is one of the natural products of fish and shellfish. Because of its advantages of rapid proliferation and low cultivation cost, sea cucumber seedlings are widely used in Taiwan. Production of rotifers and rotifers. In addition, 'Pseudococci have high levels of unsaturated fatty acids (EPA) (Apt Κ. Ε. and Behrens PW 1999 Commercial developments in microalgal biotechnology. J Phycol 35: 215- 226), also as a food additive or health food, has a high economic value. Because of the genus Erythrocyte, it can not only grow like bacteria, but also can not be reproduced by prokaryotes such as bacteria. And post-translational modification (Lin cereghin〇201024414 GPL and Gregg JM 1999 Applications of yeast in biotechnology: protein production and genetic analysis. Curr Opin Biotechnol 10: 422-4 27; Swartz JR 2001 Advances in Escherichia coli production of therapeutic proteins.. Curr Opin Biotechnol. 12: 195-201), which allows the genus Chlorella to produce complex proteins that cannot be produced by many prokaryotic bioreactors. In contrast, since the growth cycle of terrestrial plants is usually as long as one to two years, it takes more than three years to filter from the transgenic plants to the number of seeds sufficient for large-scale production. However, the algae can be in the environment for a few hours. The growth cycle can be completed within, which can greatly shorten the time required for screening and amplification of the transfer beads. In addition to rapid growth, the gametoe does not produce gametes because it does not spread like pollen due to terrestrial plants. It is contaminated by the gametes of genetically modified species, which in turn causes ecological problems. And because the Chlorella species is a seawater species, its production process does not consume a lot of fresh water and arable land like terrestrial plants, so it is more conducive to commercialization. 【Abstract】 ❿ 球 球 疋 a very promising bioreactor, and algae species of Chlorella Hong conservation techniques have also been completed (P〇ncet j.M, Ver〇n B 2〇〇3 Cry〇preseryati〇n 〇f the unicellular marine alga, Nannochloropsis oculata, Biotechnol Lett 25:. 2017-2022). Therefore, if we can transform the Chlorella algae into a bioreactor with gene transfer technology, it will make Chlorella algae a very useful biomaterial production platform. The present invention is directed to a bacterium of the genus Chlorella, which has the ability to produce a functional protein of 201024414 through gene transfer technology, and solves the high cost of use (eg, cell culture) and the south that are often encountered in current bioreactors. Time costs (eg terrestrial plant bioreactors) two major problems. The bioreactor of the invention can also absorb carbon dioxide during operation, does not need to consume limited fresh water and arable land, and can directly deliver the product to the fish and shrimp by oral feeding, which can greatly reduce the aquatic vaccine and the antibacterial protein. With the production and use cost of growth hormone, it becomes a low-cost bioreactor with both environmental protection and carbon dioxide reduction. In addition, since the Phytophthora can produce sugars and fats, and can be used as a raw material of the raw alcohol and the raw diesel, the present invention can be applied to improve the production efficiency of the biomass energy of the genus Chlorella, so the bioreactor of the present invention can be applied. In the development of biomass energy; and because the growth process of the algae will adsorb a large amount of carbon dioxide, the invention can be used to enhance the carbon dioxide adsorption efficiency of the Chlorella, and contribute to the reduction of greenhouse gases; in addition, the current aquatic products are The bait organism commonly used in the breeding industry, the invention can be used to produce aquatic oral antibacterial protein, oral vaccine to participate in oral growth hormone, etc. 'can reduce the cost of aquaculture and enhance the industrial competitiveness. The present invention transfers three different exogenous genes to Chlorella vulgaris, which are yellow fin growth hormone (rGH) which promotes fish growth, and a fusion protein which can replace antibiotics [Red Sparkle (DsRed) and Lactoferrin Protein (Bovine lactoferricin, LFB) and the surface membrane protein (VP28) of the white spot disease virus which can be used as a vaccine. After the detection of protein and biological activity tests, it can clearly show that the present invention can successfully complete the algae The gene is transferred, so that the three sources, characteristics and functions of the genus Chlorella are not the same as the exogenous protein of 201024414, and these are active from the outer egg produced by the __. The present invention provides a nucleic acid which can be expressed in a snail, which is composed of a nuclear Wei sequence encoding seqid NO: 3, wherein the nucleus can be translated into bovine lactoferrin (LFB). • In a preferred embodiment of the present invention, the killer can be operably linked to a sequence encoding a fluorescent egg, and a fusion protein of bovine lactoferrin and fluorescent protein is translated, wherein the light-colored egg (4) is used as a marker of translocation ( Seleetablemai>ke〇, which emits fluorescence in the algae strain that is transferred to the money. The transgenic line is often labeled with antibiotic resistance as a tactile marker to distinguish between transgenic and non-transgenic cells, but anti-antibiotic genes may be used. Bringing concerns about food safety and ecological damage. The present invention uses fluorescent light as a screening marker and is not hazardous for both food and environmental impact. ® In a further preferred embodiment of the invention, the nucleic acid can be additionally encoded with red The glory protein (10) is miscellaneous in the sequence of (1) to produce a fusion protein (LFB-DsRed) comprising a nucleotide sequence as shown in SEQ 1 NO: 2, which can be translated into bovine lactoferrin and red fluorescent protein, wherein The LFB and DsRed junction comprises a pepsin cutting position. In a preferred embodiment of the invention, the nucleic acid is further operably linked to a promoter, wherein the promoter is encoded as shown in SEqIDN:: 2010-0414 In a preferred embodiment of the invention, the algae are unicellular algae. In a further embodiment of the invention, the algae system is selected from the group consisting of marine or freshwater Chlorella, cypress ( Chlamydomonas'), sulcus iVolvox), Cheatocerois, three tortoises, Phaeodactylum, Skeletoneema, JVavicula, Nitzschia, sea Sealing paint (Thalassiosira) 'Amphora (Amphora), micro green ball f, CNNnochloris), iNannochloropsis, Uttrasilmis, §XDunaliella, Spirulina, 'Running ^ (Microcystis), Μ臻慝(〇scuiatoria), Isochrysis (/soc/7〇w;y), Pavlova (i^v/ονα)' or Pseudomonas sp. {Dinophyceae). In a preferred embodiment of the invention, the algae is a Chlorella. The invention further provides a method for producing an exogenous gene product in algae, comprising the steps of: a. using a proteolytic enzyme solution to weaken or remove the algal cell wall to make it suitable for gene transfer; b. encoding the foreign source Genes of sex gene products are transferred into algae; and c. Exogenous genes are expressed to obtain exogenous gene products. 201024414 The term "exogenous gene" as used in the present invention refers to a gene possessed by a non-experimental algae itself, which may be derived from bacteria, fungi, viruses, plants or animals. In a preferred embodiment of the present invention, the exogenous gene line comprises a fusion protein of bovine lactoferrin and red fluorescent protein (LFB-DsRed), a grass white spot virus surface protein (vp28) gene, or a yellow fin.鲷 Growth hormone (rYGH) gene. In a preferred embodiment of the invention, the exogenous gene product after transfection has biological activity comprising an antibacterial, antiviral' or increased growth rate, etc.; in a preferred embodiment of the invention, the biological activity comprises Vibrio cholerae (fine (10)), can be resistant to white spot syndrome baculovirus, or can increase growth rate by 2 to 3 times. The term "proteolytic enzyme" as used in the present invention refers to an enzyme which decomposes a protein, and has no source limitation, including a natural (wild type) proteolytic enzyme, and any mutants, variants (variants) having an enzyme activity. ), or fragments (etc.), etc. also include recombinant proteinases such as synthetic proteases. The "proteolytic enzyme" in the present invention includes, but is not limited to, pepsin A. The term "proteolytic enzyme solution" as used in the present invention means a mixed solution containing a proteolytic enzyme and an environmental solution capable of activating the enzyme. In a preferred embodiment of the invention, the proteolytic enzyme system comprises a synthetic gastric juice of hydrochloric acid, potassium carbonate, and pepsin A; in a preferred embodiment of the invention, the synthetic gastric juice comprises 15 mM HCl , 151111 ^ gasified potassium, 201024414 and 5% pepsin A. The traditional electroporation method uses cellulase to treat the yeast cell wall for electroporation, but it is not effective for algae. The present invention utilizes proteolytic enzymes to efficiently attenuate or remove algal cell walls, making them suitable for gene transfer. In a preferred embodiment of the invention, the algae is cultured in a 2<7 °C incubator with a light source of white Φ fluorescent light in a medium of no 2, and provides a light cycle of 10 hours of light and 14 hours of darkness. In a preferred embodiment of the invention, the gene encoding the exogenous gene product is transferred into the algae using an electroporation method; the electroporation conditions include a voltage value of 2000 v/mm and a pulse time of 20 microseconds. And the number of pulses is 1 time. Φ In a preferred embodiment of the invention, the algae are unicellular algae. In a further preferred embodiment of the invention, the algae system is selected from the group consisting of marine or freshwater green grass (Chiorelh), single cell (Chlamydomonas), wind (Volvox), 苒M f (Cheatoceros), three tortoise brown Phaeodactylum, Ske 〖etonema, Navicuh, Nitzschia, sea otter; {Thalassiosira) '_Amphora, QNarmochloris , 201024414 N 臻 (Namochbmpsis), 乌薄QTetraselmis), DunaleiUa, snail, Spirulina, tree Jt臻 (Microcystis), 臻魇Q〇scuiat〇ria), Isochrysis (Zsoc/i〇^), Pavlova (cadaverium αν/ονα), or Dinophyceae 0 In a preferred embodiment of the invention, the algae is a Chlorella. Spring The present invention further provides a genetically modified algal species whose cell wall system is weakened or removed using a proteolytic enzyme solution. In a preferred embodiment of the invention, the proteolytic enzyme solution comprises a synthetic gastric juice of hydrochloric acid, potassium carbonate, and pepsin A; in a preferred embodiment of the invention, the synthetic gastric juice comprises 150 mM hydrochloric acid, 15 mM chlorination, and 5% pepsin A. In a preferred embodiment of the invention, the algae comprises a transgenic gene encoding an exogenous gene product; wherein the exogenous gene line is from a bacterium, a fungus, a virus, a plant or an animal. In a preferred embodiment of the invention, the exogenous gene comprises a fusion protein of bovine lactoferrin and red fluorescent protein (LFB-DsRed), a grass white spot virus surface protein (VP28) gene, or a yellow fin.鲷 Growth hormone (rYGH) gene. In a preferred embodiment of the invention, the exogenous gene product can be expressed in algae and has biological activity comprising antibacterial, antiviral, or increased growth rate, etc.; in the preferred embodiment of the invention, the biologically active system Contains anti-inflammatory enterobacteria ((10)), 12 201024414 can be resistant to white spot syndrome baculovirus, or can increase growth rate by 2 to 3 times. In a preferred embodiment of the invention, the alga is a unicellular alga.
本發明之更佳實施例中,該藻類係選自一種來自海洋或淡水的綠讓 QChbrella)、翠胞蘇(iChlcmydomonas)、Μ 議;(Volvox)、肖知]讓 (Cheatoceros )、三苒褐指讓(Phaeodactylum )、骨條讓 (Skeletonema)、羽狀矽藻 QNavicula)、菱形焦 QNitzschia)、海绫 蘇(Thalassiosira)、雙Μ 臻(Amphora)、'钣綠珠臻(Nannochloris)、 擬東薄XNannochloropsis)、鳥臻 QTetraselmis)、社氏薄(DunaUeiia)、 螺旋蕉(Spirulina)、微跑M (Microcystis)、顫轍餍(〇scmatoria)、 等鞭金藻()、巴夫藻(Ρανίονα )、或橫裂假蒸 (Dinophyceae)。 本發明之最佳實施例中,該藻類係擬球藻。 本發明尚提供-種飼料組合物’其包含—種基因轉殖薄類或其子代, 其中該基因轉殖_之細胞㈣使用蛋白分解酵素液來削弱或移 除。在本發明之較佳實賴巾’該蛋自分料素液銘含贼、氣化 卸、及月蛋白酶A的合成胃液;在轉明之最佳實施例巾,該合成 13 201024414 胃液係包含150mM鹽酸、15mM氣化钾、及5%胃蛋白酶心 本發明之較佳實施例中,該基因轉殖藻類係包含編碼外源性基因產物 之轉瘦基因,其中該外源性基因係來自細菌、真菌、病毒、植物或動 物。 本發明之最佳實施例中’該外源性基因係包含牛乳鐵蛋白與紅螢光蛋 白的融合蛋白(LFB-DsRed)基因、草蝦白點病病毒表面蛋白(γρ28) 基因、或黃鰭鯛生長激素(rYGH)基因。 本發明之較佳實施例中,該外源性基因產物可在藻類中表現並具有包 含抗菌、抗病毒、或增加生長速率等之生物活性;本發明之最佳實施 例中該生物活性係包含可抗腸炎弧菌(衫知如)、 可抗白點病病毒(white spot syndrome baculovirus )、或可增加生長速In a further preferred embodiment of the invention, the algae is selected from the group consisting of a green or marine fresh water for QChbrella, iChlcmydomonas, Μ; (Volvox), Xiao Zhi] let (Cheatoceros), Sancha brown Phaeodactylum, Skeletoneema, QNavicula, QNitzschia, Thalassiosira, Amphora, Nannochloris, Jidong Thin XNannochloropsis), guanine QTetraselmis, DunaUeiia, Spirulina, Microcystis, 〇scmatoria, Isochrysis, Pavlova (Ρανίονα) Or cross-steamed (Dinophyceae). In a preferred embodiment of the invention, the algae is a Chlorella. The present invention further provides a feed composition which comprises a gene transfer subclass or a progeny thereof, wherein the cell (4) of which the gene is transferred is attenuated or removed using a proteolytic enzyme solution. In the preferred embodiment of the present invention, the egg self-separating liquid liquid contains thief, gasification unloading, and synthetic gastric juice of the protease A; in the best embodiment of the invention, the synthesis 13 201024414 gastric juice contains 150 mM hydrochloric acid , 15 mM potassium hydride, and 5% pepsin. In a preferred embodiment of the invention, the gene-transforming algae comprises a transgenic gene encoding an exogenous gene product, wherein the exogenous gene is derived from bacteria, fungi , viruses, plants or animals. In a preferred embodiment of the invention, the exogenous gene comprises a fusion protein of bovine lactoferrin and red fluorescent protein (LFB-DsRed), a grass white spot virus surface protein (γρ28) gene, or a yellow fin.鲷 Growth hormone (rYGH) gene. In a preferred embodiment of the invention, the exogenous gene product can be expressed in algae and has biological activity comprising antibacterial, antiviral, or increased growth rates, etc.; in a preferred embodiment of the invention the biologically active system comprises It can be resistant to Vibrio cholerae (known as shirt), can be resistant to white spot syndrome baculovirus, or can increase growth rate.
率2到3倍。 本發明之較佳實施例中,該藻類係單細胞藻類。 本發明之更佳實施例中,該藻類係選自一種來自海洋或淡水的綠藻 (ChloreHa)、單胞藤(Chlamyciomonas)、面綠(Volvox)、角刺漆 (Cheatoceros )、三苒褐指薄(Phaeodactylum )、骨條讓 (Skeletonema、、羽狀矽蒗 iNavicula、、菱形臻(Nitzschia)、海迷 201024414 裔{Thalassiosira)、雙Μ 議:(Amphora)、'教綠珠薄(Nannochloris)、 祿球議:〔Nannochloropsis)、烏溪(Tetraselmis)、社氏薄(ΣΗιηαΗβΠα)、 嫁旋讓(Spimlina)、微胞蘇(Microcystis)、Μ蘇屬(Oscillatoria)、 等鞭金藻()、巴夫藻(尸αν/ονα )、或橫裂假藻 (Dinophyceae) ° 本發明之最佳實施例中,該藻類係擬球藻。 本發明之較佳實施例中,該組合物係用於餵食水生生物;本發明之最 佳實施例中,該水生生物係魚或蝦。 【實施方式】 雖然本發明已以較佳實施例揭露如下,然其並非用以限定本發明。任 何熟習此技藝者,在不脫離本發明之精神和範圍内,所為之更動與潤 φ 飾,均屬發明狀專娜護細。關於發明狀賴範g當視後附之 申請專利範圍所界定者為準。 本發明實施及試驗的雜為,首先建· _表現·做好準備,並 將擬球蕩培養至飾纽,然_合成胃液(Synthetiegastriejuice) 處理擬_,觸鋪__,使其適如法進行基因轉 殖’接著㈣f纽法將外雜基則段轉錢人擬球絲生質體 中’轉殖後之擬球藻經過培養,即可選取單株讓株進行放大培養,運 15 201024414 用DNA萃取、聚合酶鏈放大反應、mRNA萃取、反轉錄聚合酶鍊放 大反應、蛋白質抽取及電泳、西方墨點法等方式檢測轉殖後之基因表 現狀況’並根據不同的轉殖基因,分別以成長實驗、溶菌環實驗、感 染實驗等方法進行檢測,確定由基因轉殖技術改造的擬球藻所表現的 外源性蛋白是否具有正常功能。 實施例1載體建構及準備The rate is 2 to 3 times. In a preferred embodiment of the invention, the alga is a unicellular alga. In a further preferred embodiment of the invention, the algae is selected from the group consisting of ChloroHa, Chlamyciomonas, Volvox, Cheatoceros, and Trichosanthes from marine or freshwater. Phaeodactylum, Skeletonema, INavicula, Nitzschia, Sea Fan 201024414 {Thalassiosira), Double Opinion: (Amphora), 'Nanonochloris' Lu ball: [Nannochloropsis), Tetraselmis, 社ιηαΗβΠα, Spimlina, Microcystis, Oscillatoria, Isochrysis (), Pakistan Algae (cadaverium αν/ονα), or Dinophyceae ° In a preferred embodiment of the invention, the algae is a Chlorella. In a preferred embodiment of the invention, the composition is for feeding aquatic organisms; in a preferred embodiment of the invention, the aquatic organism is a fish or shrimp. [Embodiment] The present invention has been disclosed in the following preferred embodiments, which are not intended to limit the invention. Anyone who is familiar with the art, without departing from the spirit and scope of the present invention, is more versatile and versatile. The invention is based on the scope of the patent application. The invention is implemented and tested. Firstly, it is prepared to prepare for the performance of the ball. The synthetic ball juice (Synthetiegastriejuice) is processed to be _, and the stencil is made to be suitable. Carrying out gene transfer' followed by (four) f-neutral method to transfer the exo-hybrids into the human spheroidal plastids. After the transfer, the spheroids are cultured, and then the individual plants can be selected for amplification and cultivation. 15 201024414 DNA extraction, polymerase chain amplification, mRNA extraction, reverse transcriptase polymerase chain amplification, protein extraction and electrophoresis, Western blotting, etc., to detect gene expression status after translocation, and according to different transgenic genes, respectively The growth test, lysate loop test, infection experiment and other methods were used to determine whether the exogenous protein expressed by the genus Chlorella transformed by the gene transfer technique has normal function. Example 1 Carrier Construction and Preparation
自 Schroda ei 〇/.( Schroda M,Blocker D,Beck CF. The HSP70A promoter as a tool for the improved expression of transgenes in Chlamydomonas. Plant J2000;21:121-31)處取得藻類表現載體的促進啟動子「Hsp70A+ RBCS2」(SEQIDNO: 1)。藉由該啟動子表現之紅螢光蛋白(DsRed) 與牛乳鐵蛋白(LFB )之融合蛋白(LFB-DsRed )的互補DNA (Complementary DNA,cDNA) (SEQIDNO : 2),則可利用下述連 續聚合酶鏈鎖反應(sequential PCR)產生。首先,模板使用含珊蝴 (Ztomsowasp.)之DsRedcDNA的pDsRed2-l (Clontech)質體。根 據用藻類密碼子最佳化後的LFB cDNA (SEQ ID NO : 3)設計3段前 置引子及1段反置引子。3段前置引子分別為CF3 ( GC TAGCACCGGTCGCCACCATGTTCAAATGTCGTCGTTGGCAATGG CGT (SEQIDNO : 4) )、CF2 (GCAATGGCGTATGAAAAAATT AGGTGCTCCTTCTATTAC ( SEQ ID NO: 5 ))、及CF1 ( CTTCTATT ACATGTGTACGTCGTGCTTTCATGGCCTCCT ( SEQ ID NO : 6 ) ) ° 反置引子則為CR (ATTTGTGATGCTATTGCTTTATTTGTAACCATT 16 201024414 (SEQIDNO : 7))。第一次PCR反應使用引子CF1和CR,進行下列 設定5個循環:94°C解離(denaturation) 30秒、30。(:黏合(annealing) 15秒、及72。〇延展(extension) 90秒。接著再進行下列設定20個循環: 94°C解離30秒、60°C黏合15秒、及72。(:延展90秒。以2%的洋菜膠電 泳分析後取出PCR產物,並將該產物用作為第二次pCR反應(同樣設 定但使用引子CF2和CR)的模板DNA。將第二次PCR反應的產物再作 為第三次PCR反應(同樣設定但使用引子CF3和CR)的模板DNA。將 φ 最終PCR反應的產物克隆(clone)至pGEM-T easy質體上。質體經限 制酵素(Nhel及EcoRV)處理後,插入pCB740載體的Nhel-EcoRV切 口處,便成為可在藻類表現LFB的載體(phr-rLFB-Red)。該載體使 用酵素(SacII)線性化’以作為之後基因轉殖之準備。 實施例2擬球藻類培養 將擬球藻培養在27°C及以白色日光燈當光源的恆溫培養箱中,使用泛2 _ 培養基(5 mg/Ι之填酸二氫納(NaH2P〇4. Η20)、75 mg/1之項酸納、 1 mg/1之生物素、1 mg/l之維生素B12、及200 mg/1之維生素B1)並 以1 : 1000的比例加入微量元素(4.36 g/Ι之乙二胺四乙酸二納鹽 (Na2EDTA)、3_15 g/Ι 之氣化鐵(FeCl3 . 6 H20)、9.8 g/Ι 之硫酸銅 (CuS04 · 5 H20)、22 g/1 之七水硫酸鋅(ZnS04.7 H20)、10 g/1 之 氯化鈷(CoCl2 . 6 H20)、18 g/1 之氣化錳 MnCl2 . 4H20、及 6.3 g/1 之 鉬酸鈉(NaMo〇4 · 2H2〇))進行培養。其光照週期為10小時光照及 14小時黑暗。當其濃度達到lxi〇7 ceus/mi時即可進行基因轉殖處理。 17 201024414 實施例3擬球藻原生質髋細胞壁處理 取40毫升之對數生長期(logphase)的野生種藻株,以8〇〇〇rpm於4。^ 離心10分鐘。每管懸浮於0.5毫升的合成胃液(15〇 mM鹽酸、15 mM 氣化钾、及5%胃蛋白酶A (來自豬的胃黏膜,sigmall4k〇〇58)),在 37 C下作用1小時。之後以8〇〇〇印爪於代離心5分鐘’懸浮於1毫升滅 菌過的海水並沖洗2次。接著在6000 rpm 4。(:離心5分鐘,將沉殿物懸 浮於70微升的EB2混合溶液(80 mM氣化鉀、5 mM氣化詞、10 mM Φ Hepes ( 4_(2_hydroxyethyl)-l-piperazineethanesulfonic acid,4-經乙基乙 磺酸)、0.2 M甘露醇、及0.2 M山梨醇)。結果顯示合成胃液能將擬球 藻分解,並能在適當的處理時間(3(K6〇分鐘)下達到削弱細胞壁的 作用(擬球藻由綠色變褐色)(圖2),使其適合以電穿孔法進行基因 轉殖。 實施例4電穿孔轉殖舆篩選 將上述的EB2混合溶液與1〇微克已線性化之外源性基因片段【分別 為可表現紅榮光(DsRed)與牛乳鐵蛋白(LFB)之融合蛋白基因(SEQ IDN0 : 2)、草蝦白點病病毒表面蛋白(γρ28) (SEqIDN〇 : 8)、 黃韓鯛生長激素(rYGH) (SEQIDN0 : 9)之藻類表現質體(圖1)】 混合後,置入電極板間隔為2毫米的電穿孔專用小玻離管(cuvette) 中’再置入電穿孔儀(electro square porator ECM T2001 BTX,USA) 的安全座中進行電穿孔基因轉殖。電穿孔條件為電壓值2〇〇〇v/mm、 脈衝時間20微秒、及脈衝次數1〇次。電破處理完成後,加入1毫升 18 201024414 之们培養基培養μ小時,之後取4〇微升塗在海水培養基,在η 持續光照下轉約1G天後。觀科祕輯放大培私進行後續 實驗。 穩疋的轉殖藻株【轉殖含有紅登光(DsRed)與牛乳鐵蛋自(LFB) 之融合蛋白基因】能在絲形成橙色18環,且此-撥色圓環能在 榮光顯微鏡m色魏。將轉酿賴料菜騎基上培養六十 天後’在轉殖藻株中有兩株(〇犯9八及〇829B )能在·周圍產生橙 色圓環(圖4A)。這些圓環能在螢光顯微鏡下觀察到紅螢光產生(圖 4E)。所用的激發光濾鏡為56〇毫微米,發射光濾鏡為61〇毫微米。 攻兩株藻株經往後DNA、RNA與蛋白質的檢測後證明的確帶有並能 表現所轉殖的外源性基因。 實施例5藻類genomic DNA萃取 取1毫升藻液,於8500 rpm 4°C離心20分鐘,倒掉上清液,將4〇〇 微升的DNA萃取緩衝液(2%溴代十六烷基三乙基銨 (cetyltrithylammonium bromide )、0.1M 三羥甲基氨基甲烷(Tris-HCl) (pH 8.0)、10mM 乙二胺四乙酸(EDTA)、j 4M 氣化鈉、及 2%p_ 硫氫乙醇(β-mercaptoethanol))’加入i.5毫升離心管渦流震盪(v〇rtex) /¾合均勻後於65 C水浴1小時’每15分鐘搖晃均勻一次。加入同體 積之酚:氣仿(phenol: chloroform)為1:1之溶液混勻,以13000 rpm 離心5分鐘,取上層溶液到新的離心管中加入兩倍體積的1〇〇%酒精, 201024414 置於-20°C冰箱沉澂至少兩小時。之後在4°C下以1300〇 rpm離心10 分鐘,再用70%酒精直接沖洗沉澱物(PeUet)兩次(每次沖洗後以 13000rpm進行離心5分鐘)’再以真空抽氣機乾燥得到沉殿物。最後 加入40微升的二次蒸餾水(ddH2〇)到樣品中,再放入55°C加熱處 理10分鐘後於-20°C保存備用。 實施例6轉殖藻株的聚合錄鍵放大反應檢測 以聚合酶鏈放大反應檢測擬球藻株是否有 藻類表現質體。以萃取出的擬球藻基因組DNA (genomicDNA)作為 模版,以轉殖基因的專一性引子 (DF : CCTCCTCCGAGAACGTCATCACCGAG (SEQ ID NO : 10) ; DR : CCTCGGTGCGCTCGTACTGCT (SEQH3N0 : 11))偵測轉殖藻株細 胞内外源性基因的存在。再配合可偵測内生性rRNA基因的引子 (nannos sF · GCGGAGGAAAAGAACTAACCAGGATT( SEQ ID NO .* 12 )及 nannos SR : AACGCCATGGCACAACCGC ( SEQ ID NO : 13 )) 作為内控制組,在聚合酶鏈反應儀器(GeneAmp PCR辦咖〇, PerkinElmer,USA)中進行35循環,其中包含了⑽解離(den纽) 3〇 秒、60。。黏合(anne—g) 30 秒、及 72。。延展(e動3〇 秒。 所有PCR的產物’取10微升於j 的洋菜膠體中進行電泳分析。其 果顯?r外職基在電錄2⑻Q v/mm、脈衝咖Μ微秒、及 Γ衝人數10 -人的電穿孔處理條件下,成功的進入擬球藻體内,並在 第一代達到100%的轉殖率(圖3 )。 20 201024414 實施例7藻類mRNA的萃取 當藻株培養到濃度約lxlO7 cell/ml後,取50毫升藻液在4°C下以8000 rpm離心5分鐘。加入1毫升的RNA分離試劑(tri® Reagent抓八Promoting promoters for algae expression vectors from Schroda ei 〇/. (Schroda M, Blocker D, Beck CF. The HSP70A promoter as a tool for the improved expression of transgenes in Chlamydomonas. Plant J2000; 21:121-31) Hsp70A+ RBCS2" (SEQ ID NO: 1). By the complementary DNA (Complementary DNA, cDNA) (SEQ ID NO: 2) of the fusion protein of red fluorescent protein (DsRed) and lactoferrin (LFB) (LFB-DsRed) expressed by the promoter, the following continuous Polymerase chain reaction (sequential PCR) is produced. First, the template used pDsRed2-l (Clontech) plastid containing DsRed cDNA of Ztomsowasp. A 3-stage pre-introduction and a 1-segment trans-introduction were designed based on the LFB cDNA (SEQ ID NO: 3) optimized with the algae codon. The three pre-primers are CF3 (GC TAGCACCGGTCGCCACCATGTTCAAATGTCGTCGTTGGCAATGG CGT (SEQIDNO: 4)), CF2 (GCAATGGCGTATGAAAAAATT AGGTGCTCCTTCTATTAC (SEQ ID NO: 5)), and CF1 (CTTCTATT ACATGTGTACGTCGTGCTTTCATGGCCTCCT (SEQ ID NO: 6)) ° inverse primer. Is CR (ATTTGTGATGCTATTGCTTTATTTGTAACCATT 16 201024414 (SEQIDNO: 7)). The first PCR reaction was carried out using the primers CF1 and CR for the following five cycles: 94 ° C denaturation for 30 seconds, 30. (: annealing for 15 seconds, and 72. ex extension for 90 seconds. Then set the following 20 cycles: 94°C dissociation for 30 seconds, 60°C for 15 seconds, and 72. (: extension 90 Seconds. After electrophoresis analysis with 2% acacia gel, the PCR product was taken out and used as the template DNA for the second pCR reaction (also set using primers CF2 and CR). The product of the second PCR reaction was As a template DNA for the third PCR reaction (also set up but using primers CF3 and CR), the product of the φ final PCR reaction was cloned onto the pGEM-Teasy plastid. The plastid regulated enzyme (Nhel and EcoRV) After the treatment, the Nhel-EcoRV nick of the pCB740 vector was inserted into a vector capable of expressing LFB in algae (phr-rLFB-Red). The vector was linearized with an enzyme (SacII) as a preparation for subsequent gene transfer. Example 2 Chlorella cultures Chlorella was cultured in a constant temperature incubator at 27 ° C with a white fluorescent lamp as a light source, using a pan- 2 _ medium (5 mg / Ι acid dihydrogen sodium (NaH2P 〇 4. Η 20) , 75 mg/1 acid sodium, 1 mg/1 biotin, 1 mg/l vitamin B12, and 200 Mg/1 vitamin B1) and added trace elements (4.36 g / 乙 ethylenediaminetetraacetic acid di-nano salt (Na2EDTA), 3_15 g / Ι of gasified iron (FeCl3 . 6 H20), in a ratio of 1:1000, 9.8 g/Ι copper sulfate (CuS04 · 5 H20), 22 g/1 zinc sulfate heptahydrate (ZnS04.7 H20), 10 g/1 cobalt chloride (CoCl2. 6 H20), 18 g/1 Gasification of manganese MnCl2. 4H20, and 6.3 g/1 of sodium molybdate (NaMo〇4 · 2H2〇)). The photoperiod is 10 hours light and 14 hours dark. When the concentration reaches lxi〇7 ceus/mi Gene transfer treatment can be performed. 17 201024414 Example 3 Protoplast protoplast hip cell wall treatment Take 40 ml of log phase wild-type algae strain and centrifuge at 8 rpm for 10 minutes at 4 rpm. Each tube was suspended in 0.5 ml of synthetic gastric juice (15 mM HCl, 15 mM potassium sulphate, and 5% pepsin A (from porcine gastric mucosa, sigmall 4k 〇〇 58)) and allowed to act at 37 C for 1 hour. Then, it was suspended in 1 ml of sterilized seawater by centrifugation for 5 minutes with 8 inches of paws and rinsed twice. Then at 6000 rpm 4. (: Centrifuge for 5 minutes, suspend the suspended matter in 7 0 microliters of EB2 mixed solution (80 mM potassium carbonate, 5 mM gasification, 10 mM Φ Hepes (4_(2_hydroxyethyl)-l-piperazineethanesulfonic acid, 4-ethyl ethanesulfonic acid), 0.2 M mannitol, And 0.2 M sorbitol). The results showed that the synthetic gastric juice can decompose the Chlorella, and can achieve the effect of weakening the cell wall under appropriate treatment time (3 (K6〇 min)) (The Chlorella spp. changes from green to brown) (Fig. 2), making it suitable for electricity. The gene was transfected by perforation method. Example 4 Electroporation and transmutation screening The above-mentioned EB2 mixed solution and 1 〇 microgram of linearized exogenous gene fragments were respectively expressed as Red Glory (DsRed) and bovine lactoferrin ( LFB) fusion protein gene (SEQ ID NO: 2), grass shrimp white spot virus surface protein (γρ28) (SEqIDN〇: 8), yellow Han 鲷 growth hormone (rYGH) (SEQ ID NO: 9) algae expressing plastids ( Figure 1)] After mixing, place the electrowell in a small hole-free tube (cuvette) with an electrode plate spacing of 2 mm and re-insert the electroporator (electro square porator ECM T2001 BTX, USA). The perforation gene was transferred. The electroporation conditions were voltage value 2〇〇〇v/mm, pulse time 20 microseconds, and pulse number 1 times. After the electroporation treatment, 1 ml of 18 201024414 medium was added for μ hour. Then take 4 〇 microliters coated in seawater medium After about 1G of day under η continuous illumination, the observational secrets were amplified and carried out for subsequent experiments. The stable transgenic algae strain [transformed with fusion protein of red smear (DsRed) and bovine milk iron egg (LFB) The gene can form an orange 18 ring in the silk, and this - the color ring can be colored in the glory microscope. After cultivating for 60 days on the substrate, there are two in the transgenic plant. 〇 9 八 八 and 〇 829B ) can produce orange rings around (Figure 4A). These rings can observe red fluorescence under the fluorescence microscope (Figure 4E). The excitation filter used is 56〇 The nanometer, emission filter is 61 〇 nanometer. After the detection of DNA, RNA and protein by the two strains of algae, it proves that it carries and can express the exogenous gene transferred. Example 5 algae genomic DNA extraction 1 ml of algae solution was centrifuged at 8500 rpm for 4 minutes at 4 ° C. The supernatant was decanted and 4 μL of DNA extraction buffer (2% cetyltrithyltriethylammonium (cetyltrithylammonium) Bromide ), 0.1 M Tris-HCl (pH 8.0), 10 mM ethylenediaminetetraacetic acid (EDTA), j 4M gasification And 2% p_ sulphuric acid (β-mercaptoethanol)) 'Add i.5 ml centrifuge tube vortex vortex (v〇rtex) /3⁄4 and mix evenly in a 65 C water bath for 1 hour 'shake every 15 minutes evenly. Join the same Volume of phenol: phenol: chloroform is 1:1 solution, centrifuge at 13000 rpm for 5 minutes, take the upper layer solution into a new centrifuge tube and add twice the volume of 1% alcohol, 201024414 -20 ° C refrigerator for at least two hours. After that, it was centrifuged at 1300 rpm for 10 minutes at 4 ° C, and the precipitate (PeUet) was directly washed twice with 70% alcohol (centrifugation at 13,000 rpm for 5 minutes after each rinsing), and then dried by a vacuum aspirator to obtain a sink. Temple. Finally, 40 μl of double distilled water (ddH2〇) was added to the sample, which was further heated at 55 ° C for 10 minutes and then stored at -20 ° C until use. Example 6 Polymerization of a transgenic strain of a transgenic strain was detected by a polymerase chain amplification reaction to detect whether the algae strain had an algal expressing plastid. Using the extracted genomic DNA as a template, the transgenic gene specific primer (DF: CCTCCTCCGAGAACGTCATCACCGAG (SEQ ID NO: 10); DR: CCTCGGTGCGCTCGTACTGCT (SEQH3N0: 11)) was used to detect the transgenic strain. The presence of intracellular and exogenous genes. Further, an intron-detecting endogenous rRNA gene (nannos sF · GCGGAGGAAAAGAACTAACCAGGATT ( SEQ ID NO .* 12 ) and nannos SR : AACGCCATGGCACAACCGC ( SEQ ID NO : 13 )) was used as an internal control group in the polymerase chain reaction apparatus (GeneAmp). The PCR cycle, PerkinElmer, USA) was carried out for 35 cycles, including (10) dissociation (den New) 3 sec, 60. . Bond (anne-g) 30 seconds, and 72. . Extension (e move 3 sec. All PCR products 'take 10 microliters of j in the colloidal colloid for electrophoretic analysis. The fruit is shown in the external record in the electric record 2 (8) Q v / mm, pulse coffee microseconds, And the number of people under the electroporation treatment of 10 people was successfully entered into the genus Chlorella, and reached the 100% conversion rate in the first generation (Fig. 3). 20 201024414 Example 7 Extraction of algal mRNA After the algae strain was cultured to a concentration of about lxlO7 cell/ml, 50 ml of algae solution was centrifuged at 8000 rpm for 5 minutes at 4 ° C. Add 1 ml of RNA isolation reagent (tri® Reagent catching eight)
Isolation Reagent) (Sigma Chemicals, St. Louis, USA),渴流震盡30秒Isolation Reagent) (Sigma Chemicals, St. Louis, USA), thirsty flow shocks for 30 seconds
後靜置冰上30秒。將此步驟重複5次後加入200微升氣仿,在室溫下旋 轉混合10〜15分鐘(或渦流震盪2分鐘,冰上靜置1〇分鐘)。於4°c以 10000 rpm離心30分鐘,吸上清液,加入適量RQ1無核糖核酸酶After standing on the ice for 30 seconds. Repeat this step 5 times, add 200 μl of gas, and mix for 10 to 15 minutes at room temperature (or vortex for 2 minutes and let stand for 1 minute on ice). Centrifuge at 10000 rpm for 30 minutes at 4 ° C, aspirate the supernatant, and add the appropriate amount of RQ1 ribonuclease.
(RNase)之去氧核糖核酸酶 I (DNasel) (Promega,M6101)於37°C 作用40分鐘’加入0.7倍艘積異丙醇室溫沉澱15分鐘,於4°c以13000 rpm離心30分鐘,倒掉上清液,70%酒精洗鹽,於以13000 rpm離心 10分鐘’倒上清液’供乾。加入50微升無核糖核酸酶的水,再加入等 體積LiCl (為了去掉醣蛋白),_2〇。(:沉澱至少三小時。之後在4。〇下以 13000 rpm離心30分鐘’倒上清液,70%酒精洗鹽,4。(:全速離心10分 鐘,倒上清液。烘乾後加30微升無核糖核酸酶的水回溶沉澱物,保存 -20〇C。 實施例8反轉錄聚合錄鍵放大反應 使用反轉錄聚合酶鏈放大反應觀察擬球藻經熱休克誘導後細胞内轉 殖基因表現情形。設計適當的引子,以PCR方式放大出轉殖基因的轉 錄後產物。首先,取15微升RNA (2 ug),加入1微升寡聚脫氧胸苷 酸(OligodT)引子(SEQIDN0: 14),70°C作用15分鐘(雙股分離), 21 201024414 加入5微升5XM-MLV反轉錄酶緩衝液、2微升lOmM去氧核苷三磷 酸(dNTP)、1 微升 RNA 酶抑製劑(rRNasin ) (4〇υ/μ1,Promega, N2511)在42C作用15分鐘(黏合),再加入1微升μ-MLV反轉錄 酶於42°C作用1小時之後以70°c作用15分鐘(去活化)。後冰上3 分鐘,保存於-2〇°C。 結果顯示外源性基因的確能在轉殖擬球藻中進行轉錄,且實驗並未遭 到污染(圖5)。 實施例9藻類蛋白質抽取及蛋白質電泳 將適量藻液以8000 rpm離心20分鐘的沉澱物溶在藻類蛋白質萃取緩 衝液(不含10%蔗糖)裡,與β·硫氫乙醇及苯甲基磺氟(pMSF) (2〇〇 mol/1)加入内含滅菌處理過之小玻璃珠(beads)的15毫升微量離心 管中。將每個微量離心管依序放到小型震盪式組織研磨器 (mini-beadbeater)中搖晃均勻,每次20秒共16次。於4°C以13000 rpm離心10分鐘,吸出上清液至新的微量離心管裡,取1/5體積的5χ 樣品緩衝液((312.5 mMTris-Cl (ρΗ6.8)、20%甘油(ν/ν)、及 4.6% 十二烧基硫酸鈉(Sodium dodecyl sulfate,SDS (w/v))至樣品中, 均勻混合。將樣品放到100°C沸水中煮5分鐘(使蛋白質變性),置於 冰上5分鐘,使不再作用以穩定之。在每個1.5毫米聚丙烯醯胺膠體 槽(polyacrylamide gel well)裝載入30微升的樣品,以130伏特的電 壓於電泳緩衝液(25 mM三羥曱基氨基甲烷(Tris base )、0.192 Μ甘 胺酸、及0.1% SDS (最後加入))作用3小時。 22 201024414 實施例10西方點墨法 蛋白質電泳結束後將硝酸纖維膜(nitrocellulose membrane)、適當大 小的3毫米紙張以及海綿網置於轉膜緩衝液(transferbufffer ; 25mM三 羥甲基氨基甲烷(Tris base)、0.192 Μ甘胺酸、及0.1% SDS (w/v) 潤濕15分鐘。將蛋白質電泳完成的膠體平鋪在3毫米紙張上,其上再 鋪上硝酸纖維膜及3毫米紙張並放入轉印系統中’由負極往正極的方 向放置(不能有氣泡產生)並開啟開關使電流維持在4〇〇毫安培轉印! 小時。轉印完成後將確酸纖維膜取出並浸泡在1 x 中(Tris_HQ緩 衝鹽溶液;含150 mM氣化鈉、25 mM三苯基膦(Tris) (pH 7.5)、5% 脫脂牛奶、及0.1%乳化劑(Tween20)),於37°C進行1.5小時或於4°C 進行12小時(一整夜)的阻隔作用(blocking)。而後再用1 xpBST或 TBST潤濕兩次,加入適當的一次抗體於TBS溶液中(含1%脫脂牛 奶),於4°C作用一整夜或於25。(:作用1小時。接著用丨x PBST (磷酸 鹽緩衝液(PBS) 5x稀釋至lx並加入0.05% (v/v) Tween2〇)或xbsT (含1/。脫脂牛奶及0.1%乳化劑(Tween2〇))洗三次,每次15分鐘, 再用1 X TBST潤濕兩次後浸泡在j x jjgs中,於37。匸進行阻隔作用 (blocking) 1.5小時。加入! : : 2〇〇〇〇的二級抗體於TBS溶 液(含1%脫脂牛奶),於25°C作用1小時。用丨x PBST或TBST洗三次, 每-人15为鐘。用偵測緩衝液(detecti〇n ;1〇〇丁出讲9 5、 100 mM氣化納、5 mM氣化鎂)潤濕j〇分鐘。加人呈色劑⑽T/BCIp ) 靜置呈色(每10毫升的偵測緩衝液加人2〇峨升的仰丁脱逆貯存溶 23 201024414 液)。 、σ果顯示轉殖擬球藻在熱誘導處理後產生能被抗體標*外源性蛋白 實施例11生物活性試驗 根據不同的轉殖基因,分取成長實驗、溶_實驗、絲實驗等方 法進行檢ΛΙ破疋自基目轉g技術改擬球帛所^^的外源性蛋白 是否具有正常功能。 轉殖域生關轉雜球齡韻錢,贿_實缝視其抗菌 活性。不同體積的轉殖擬球藥㈤〇7cell/ml)經過熱誘導處理後, 利用合成胃液於听下處理4小時職分解,並置於摊0.5公分 的圓形紙壯,在含有腸炎弧_培養基上於坑下培養%小時。 !用不同劑量峡tb轉作為殺醜力參考減。其結果顯示經過 .,、、誘導處理的轉殖擬球魏在經過合成胃液分解後產生殺菌能力, 每一個轉殖擬球藻細胞的_能力相當於3.㈣·8微克安比西林 (ampicillin)(圖 7) 〇 24 201024414 表1.以擬球藻餵食青鱗魚 等以腸炎狐菌感染後24小時之存活率似、 注射 感染\\ Dsw W.T. TL TH Dsw 95±7.1 95±7.1 95±7.1 — 1〇〇 Cont. 90 100 100 __ 95gT^~ 95±7~i VP-L 15±7.1 10 65±21.2~ VP-H 0 5±7.1 70 85±7Τ~~~~ * Dsw: 10 μΐ蒸餾海水 * Cont:負控制組,高劑量的死菌(煮沸30分鐘)K (lxl05cells/fish) * VP-L:低劑量的活菌 Kpara/zae/wo如/cms (lxl〇4cells/fish) * VP-H:高劑量的活菌 (lxl〇5 cells/fish) *W.T.:野生種擬球藻(ixi〇8ceUs/fish) *TL:低劑量轉殖擬球藻(lxl〇6cells/fish) * ΤΗ:高劑量轉殖擬球藻(lxl〇8 cells/ fish) *各組實驗樣本數均為10,數據為三重覆後取平均值。 ❹ 以口服注射的方式將擬球藻送入青鏘魚之消化道,並於6小時後以 相同方式送入腸炎弧菌進行感染實驗。並於感染後24小時計算存活 率。結果顯示轉殖擬球藻的確能保護青鏘魚不因腸炎弧菌的感染而 死亡。其保護效果在lxl〇5eells/fish劑量的腸炎弧菌感染下可以達到 八成以上的存活率,而餵食野生種擬球藻在同樣感染條件下的死亡 率超過九成。這顯示擬球藻所表現的抗菌蛋白具有正常活性(表1)。 25 201024414 將草瑕注射白點病毒以進加服疫苗❹試驗之齡狀天數計 算草瑕死亡率。草瑕累軸亡料統計結果㈣來自饒食含野生 藻1/2野生藤+1/2轉殖藻、轉殖藻及银食一般飼料的正控制組和負 控制組的各個實驗_ (N=⑻此為三次重複實驗平均值畫出的結 果。正控制組和負控制組:飯食一般飼料;轉基因藻類:飯食包覆 VP28轉殖藻的飼料;1/2野生型+ 1/2轉基因藻類··假食包覆μ野 生型和1/2VP28轉__料;野生型:餵食包覆野生藻的飼料。 正控制組、轉基因藻類、野生型和1/2野生型+ 1/2轉基因藻類:注 射白點病毒液。負控制組:注射PBS液。其結果如圖8所示。 表2. 錯鋼f長激素基因的轉殖擬球藻在透過豐年蝦餵 培養 時間 飯食的 豐年蝦 平均髖重(g) 增加重 量 平均趙長(cm) 增加髏 條件因 (小 時) 最初 最终 (%) 最初 最终 長(%) 子 4 野生型 轉基因 〇·23±〇.〇 la 0.43±0.0 T 87±3.2a 1.36±〇.〇 la 3.27 土 0.1 Oa 139±4.2a 12.0±〇·〇 la 0·23±〇·〇 la 0.77 土 0.0 9b 232±7.1b 1.36±〇.〇 la 3.98±0.1 7b 197 土 7.5b i2.i±〇〇 2a 6 野生型 0.23±0.0 la 0.47±0.0 6C 104±4.Γ 1.36±〇,〇 la 3.35±0.1 3C 146±5.5C 12.2±〇.〇 〇a 轉基因 0.23±0.0 la 0.98 士 0.1 4d "316±9?7^ 1.36±〇.〇 la 4.38±0.2 3d 217±8.9厂 L 12.0±〇.〇 1 a *公,A卞叼值±SD表示 --- 每組n=2〇隻紅色吳郭备苗 1 iwmL_< W ocw/αία (1 X l〇5個細胞) 差異(p<0.0 5) 1 ❿ 26 201024414 將野生型與含有黃賴生長激素基關轉殖擬顧透過豐年瑕健食 紅色吳郭魚,並記離色吳郭魚之生長航,結果顯雜食含有黃韓 鯛生長激《目_麵雜幫敝㈣誠快賴餘,體重增加 速率比飯食野生觀絲的_高兩到三倍,體長增加也將近兩倍 (表2)。此一結果顯示轉殖擬球藻所生產的魚類生長因子能具有生 物活性。 【圖式簡單說明】 圖1顯示表現載體phr-LFB-Red,其用以使藻類產生融合紅螢光蛋白 (RFP (DsRed))之重組牛乳鐵蛋白(b〇vine iact〇ferricin ; 。(RNase) Deoxyribonuclease I (DNasel) (Promega, M6101) was applied at 37 ° C for 40 minutes. Add 0.7 times of isopropanol at room temperature for 15 minutes, and centrifuge at 13,000 rpm for 30 minutes at 4 ° C. The supernatant was decanted, washed with 70% alcohol, and centrifuged at 13,000 rpm for 10 minutes to 'pour the supernatant' for drying. Add 50 μl of ribozyme-free water and add an equal volume of LiCl (to remove the glycoprotein), _2 〇. (: Precipitate for at least three hours. After centrifugation at 13,000 rpm for 30 minutes under the armpits, pour the supernatant, wash the salt with 70% alcohol, 4. (: Centrifuge at full speed for 10 minutes, pour the supernatant. Add 30 after drying) Microliters of ribonuclease-free water-resolved precipitate, stored at -20 ° C. Example 8 Reverse transcription polymerization, transcriptional amplification, reverse transcription polymerase chain amplification, observation of intracellular transformation after induction of heat shock by Chlorella Gene expression situation. Design appropriate primers to amplify the post-transcriptional product of the transgenic gene by PCR. First, take 15 microliters of RNA (2 ug) and add 1 μl of oligo-deoxythymidine (OligodT) primer (SEQ IDN0). : 14), at 70 ° C for 15 minutes (double strand separation), 21 201024414 Add 5 μl of 5XM-MLV reverse transcriptase buffer, 2 μl of 10 mM deoxynucleotide triphosphate (dNTP), 1 μl of RNase The inhibitor (rRNasin) (4〇υ/μ1, Promega, N2511) was applied at 42C for 15 minutes (bonding), and 1 μl of μ-MLV reverse transcriptase was added to act at 42 ° C for 1 hour and then acted at 70 ° C. Minutes (deactivation). After 3 minutes on ice, stored at -2 °C. The results show that the exogenous gene can indeed Transcription was carried out in Chlorella vulgaris, and the experiment was not contaminated (Fig. 5). Example 9 Algae protein extraction and protein electrophoresis The appropriate amount of algae solution was centrifuged at 8000 rpm for 20 minutes to dissolve in the algae protein extraction buffer. In the liquid (excluding 10% sucrose), add 15 ml of micro-beads containing sterilized beads to β·thiol and benzylsulfonate (pMSF) (2〇〇mol/1). In a centrifuge tube, place each microcentrifuge tube in a small vibrating tissue mill (mini-beadbeater) and shake it evenly for 16 times each time for 20 seconds. Centrifuge at 13000 rpm for 10 minutes at 4 °C. Clear the solution into a new microcentrifuge tube and take 1/5 volume of 5 样品 sample buffer ((312.5 mMTris-Cl (ρΗ6.8), 20% glycerol (ν/ν), and 4.6% sodium dodecyl sulfate) (Sodium dodecyl sulfate, SDS (w/v)) to the sample, mix evenly. Put the sample in boiling water at 100 ° C for 5 minutes (denature the protein), put it on ice for 5 minutes, so that it no longer acts to stabilize Load 30 μl of sample into each 1.5 mm polypropylene polyacrylamide gel well. A voltage of 130 volts was applied to the running buffer (25 mM Tris base, 0.192 Μglycine, and 0.1% SDS (final addition)) for 3 hours. 22 201024414 Example 10 Western blotting method After protein electrophoresis, a nitrocellulose membrane, an appropriately sized 3 mm paper, and a sponge mesh were placed in a transfer buffer (25 mM Tris base, 0.192 Μglycine, and 0.1% SDS (w/v) for 15 minutes. The gel electrophoresed by the protein was spread on a 3 mm paper, which was coated with a nitrocellulose membrane and a 3 mm paper and placed in a transfer system. 'The anode was placed in the direction of the positive electrode (no bubbles were generated) and the switch was turned on. Keep the current at 4 mA amp transfer! hour. After the transfer is completed, the acid fiber membrane is taken out and immersed in 1 x (Tris_HQ buffered saline solution; containing 150 mM sodium hydride, 25 mM triphenylphosphine (Tris) (pH 7.5), 5% skim milk, and 0.1 % emulsifier (Tween 20)) was blocked at 37 ° C for 1.5 hours or at 4 ° C for 12 hours (one night). It is then wetted twice with 1 xpBST or TBST, and the appropriate primary antibody is added to the TBS solution (containing 1% skim milk) and allowed to act overnight at 4 °C or at 25. (: for 1 hour. Then dilute with 丨x PBST (phosphate buffer (PBS) 5x to lx and add 0.05% (v/v) Tween2〇) or xbsT (containing 1%. skimmed milk and 0.1% emulsifier ( Tween2〇)) Wash three times for 15 minutes each time, then wet twice with 1 X TBST and soak in jx jjgs at 37. Blocking for 1.5 hours. Add! : : 2〇〇〇〇 The secondary antibody was applied to TBS solution (containing 1% skim milk) for 1 hour at 25 ° C. Wash three times with 丨x PBST or TBST for 15 minutes per person. Use detection buffer (detecti〇n; 1 〇〇丁讲讲9 5, 100 mM gasification sodium, 5 mM magnesium sulphate) Wetting for j〇 minutes. Adding coloring agent (10)T/BCIp) Resting color (per 10 ml of detection buffer added) 2 soaring Yang Ding reversing storage solution 23 201024414 liquid). σ fruit shows that the C. elegans can be produced by the antibody after the heat-induced treatment. Exogenous protein Example 11 Biological activity test According to different transgenic genes, the growth experiment, dissolution _ experiment, silk experiment, etc. It is necessary to check whether the exogenous protein of the spheroidal sputum has a normal function. The transfer of the field to the end of the mixed ball age rhyme money, bribery _ real seam depending on its antibacterial activity. Different volumes of transgenic globulins (5) 〇7cell/ml) were treated with heat-induced treatment, and then treated with synthetic gastric juice for 4 hours of occupational decomposition, and placed in a circular paper of 0.5 cm, on the medium containing enteritis Cultivate for 1 hour under the pit. Use different doses of gorge tb turn as a reference to kill ugly power. The results showed that after the induction treatment, the transgenic globules of the genus Wei had a bactericidal ability after being decomposed by the synthetic gastric juice, and the _ ability of each of the transgenic Phytophthora cells was equivalent to 3. (four)·8 micrograms of ampicillin (ampicillin) (Fig. 7) 〇24 201024414 Table 1. Survival rate of 24 hours after infection with Phytophthora, such as Phytophthora, infection \\ Dsw WT TL TH Dsw 95±7.1 95±7.1 95±7.1 — 1〇〇Cont. 90 100 100 __ 95gT^~ 95±7~i VP-L 15±7.1 10 65±21.2~ VP-H 0 5±7.1 70 85±7Τ~~~~ * Dsw: 10 μΐ distillation Seawater* Cont: Negative control group, high dose of dead bacteria (boiled for 30 minutes) K (lxl05cells/fish) * VP-L: low dose of live bacteria Kpara/zae/wo such as /cms (lxl〇4cells/fish) * VP-H: high dose of live bacteria (lxl〇5 cells/fish) *WT: wild species of Chlorella vulgaris (ixi〇8ceUs/fish) *TL: low dose of Chlorella vulgaris (lxl〇6cells/fish) * ΤΗ: High dose of Chlorella vulgaris (lxl〇8 cells/fish) * The number of experimental samples in each group was 10, and the data was averaged after triple coverage.拟 The algae were sent to the digestive tract of the squid by oral injection, and the Vibrio cholerae was sent to the infection experiment in the same manner after 6 hours. Survival rates were calculated 24 hours after infection. The results showed that C. elegans did protect the barley from death from Vibrio cholerae infection. Its protective effect can reach more than 80% survival rate under the infection of Vibrio cholerae at lxl〇5eells/fish, while the mortality rate of wild-type Chlorella vulgaris under the same infection conditions is over 90%. This shows that the antibacterial protein exhibited by Chlorella has normal activity (Table 1). 25 201024414 Calculate the mortality of grasshoppers by using the white spot virus of the grasshopper to enter the age of the vaccine. The statistical results of the grasshoppers and the axillary dead bodies (4) from the positive control group and the negative control group of the wild algae 1/2 wild vine + 1/2 transgenic algae, transgenic algae and silver food general feed _ (N = (8) This is the result of the average of three replicate experiments. Positive control group and negative control group: general feed for meals; genetically modified algae: feed for VP28 transgenic algae; 1/2 wild type + 1/2 transgenic algae ··Fake food coating μ wild type and 1/2 VP28 turn; wild type: feeding feed coated with wild algae. Positive control group, transgenic algae, wild type and 1/2 wild type + 1/2 transgenic algae : Injection of white spot virus solution. Negative control group: injection of PBS solution. The results are shown in Fig. 8. Table 2. The average of the brine-shrunk shrimps of the miscible g-long-hormone gene in the culture of the brine Hip weight (g) increase weight average Zhao long (cm) increase 髅 condition factor (hour) initial final (%) initial final length (%) sub 4 wild type transgenic 〇·23±〇.〇la 0.43±0.0 T 87± 3.2a 1.36±〇.〇la 3.27 Soil 0.1 Oa 139±4.2a 12.0±〇·〇la 0·23±〇·〇la 0 .77 土 0.0 9b 232±7.1b 1.36±〇.〇la 3.98±0.1 7b 197 soil 7.5b i2.i±〇〇2a 6 wild type 0.23±0.0 la 0.47±0.0 6C 104±4.Γ 1.36±〇, 〇la 3.35±0.1 3C 146±5.5C 12.2±〇.〇〇a Transgenic 0.23±0.0 la 0.98 ± 0.1 4d "316±9?7^ 1.36±〇.〇la 4.38±0.2 3d 217±8.9 Plant L 12.0 ±〇.〇1 a *Male, A卞叼±SD indicates --- n=2〇 each group of red Wu Guobei seedlings 1 iwmL_< W ocw/αία (1 X l〇5 cells) difference (p<0.0 5) 1 ❿ 26 201024414 The wild type and the yellow-growth-promoting hormone-based gene were transferred to the red mullet, and the growth of the scorpionfish was recorded.激 目 目 目 目 目 目 目 目 目 目 目 目 目 目 目 目 目 目 目 目 目 目 目 目 目 目 目 目 目 目 目 目 目 目 目 目 目 目 目 目 目 目 目 目 目 目 目 目 目 目 目 目 目The fish growth factor produced by the algae can be biologically active. [Simplified illustration] Figure 1 shows the expression vector phr-LFB-Red, which is used to make algae produce recombinant red fluorescent protein (RFP (DsRed)) recombinant bovine milk iron. Protein (b〇vine iact〇ferricin;
Hsp70A+ RBCS 2 ’ Chlamydomonase reinhardtii 的熱休免蛋白 7QA 基西 之啟動子與1,5-二磷酸核酮糖羧化酶/加氧酶小次體2基因 (ribulose-l,5-bisphosphate carboxylase/oxygenase small subunit 2 gene) 之啟動子的融合。rLFB :重組藻類密碼子最佳化的 (algae-codon-optimized )LFB 〇 DsRed:珊瑚(D如oioma sp.)( Clontech ) 之紅色螢光蛋白基因。箭頭指示以胃蛋白酶作用後所釋放出之功能性 區域的位置。AM及五coRV為在PCB740載體中插入編碼融合蛋白 (LFB-DsRed)之DAN片段之切點。DF及DR為用以篩選含有 phr-rLFB-Red之蒸類轉殖株的引子,預期會放大產生一 450-bp的PCR 產物。 27 201024414 。兩旁的數字表示擬 圖2顯示利用合成胃液進行擬球騎處理之效果 球藻經合成胃液處理的時間。Hsp70A+ RBCS 2 ' Chlamydomonase reinhardtii's heat-removing protein 7QA keith promoter and 1,5-bisphosphate ribulose carboxylase/oxygenase small corpuscle 2 gene (ribulose-l, 5-bisphosphate carboxylase/oxygenase Small subunit 2 gene) Fusion of promoters. rLFB: recombinant algae codon-optimized (algae-codon-optimized) LFB 〇 DsRed: coral (D such as oioma sp.) (Clontech) red fluorescent protein gene. The arrow indicates the location of the functional area released by the action of pepsin. AM and five coRV are the cut-points of the DAN fragment encoding the fusion protein (LFB-DsRed) inserted into the PCB740 vector. DF and DR are primers used to screen for steam-transgenic strains containing phr-rLFB-Red, which are expected to amplify a 450-bp PCR product. 27 201024414. The numbers on both sides indicate that Figure 2 shows the effect of using the synthetic gastric juice for the ball-riding treatment. The time when the cyanobacteria is treated with the synthetic gastric juice.
❹ 圖3顯示利用PCR方式檢測經不同條件處理後的擬球藻(第一幻的 體染色體中是否含有轉殖基因。M:分子量標的。n:不含模板之負 控制組。p:含lng轉殖翻之正射m野生觀球藻之體染 色體° 1〜11 :經基因轉殖處理之擬球藻體染色髏。⑷:以ikv進 行電穿孔。(B):以2kV進行電穿孔。 ® 4 _⑷:洋菜培養基上培養六十天後,在轉 殖藻株中有兩株(〇829A及〇82阳)能在蕩落周圍產生撥色圓環。⑻ 野生型或轉殖不穩定的藻株,其周圍沒有橙色圓環。(c):周圍沒有 撥色圓環的藻株,在榮光顯微鏡下也不會產生紅螢光。(D):周圍有 撥色圓環的藻株。(E):周圍有橙色圓環的藻株能在螢光顯微鏡下觀 察到紅螢光產生。 圖5顯示利用RT-PCR檢測經熱誘導處理後的擬球藻體是否能轉錄外 源性基因。Μ :分子量標的。N :不含模板之控制組。p :含lng轉 殖基因之正控制組。W:野生種擬球藻之體染色體。1〜4 :經基因轉 殖處理之擬球藻體染色體。LF-LR:可放大出轉殖基因編碼區之引子 組’可得知外源性基因是否有在轉殖擬球藻中進行轉錄。PF-LR :可 放大出轉殖基因之啟動子與編碼區之引子組,能檢視實驗是否有遭到 轉殖基因質體之DNA污染。 28 201024414 圖6顯示利用SDS-PAGE分析轉殖擬球藻在熱誘導處理前後的總蛋 白質,並配合適當的抗體進行西方點墨法檢測。(A):取5〇毫升濃度 為lxlO7 cell/ml的擬球藻以SDS-PAGE ( 12 %)進行擬球藻蛋白質分 析。]VI .分子量標的。W :野生種擬球藻之總可溶性蛋白質。丁:轉 殖藻之總可溶性蛋白質。熱休克:於42。〇持續光照情況下培養16小 時。(B):以適當的一次抗體偵測轉殖擬球藻是否能表現外源性蛋白, % 箭頭所指的位置是被抗體標示的外源性蛋白。 圖7顯示以溶菌環試驗檢視轉殖抗菌胜肽的轉殖擬球藻經過消化 後,其抗菌活性。 圖8顯示口服疫苗感染試驗中,注射白點病毒後的天數與草瑕死亡 率關係圖。注射後天數:白點病毒注射後天數;累積死亡率⑻: 草瑕累積死亡率。在線旁邊邊標記有星賴稍是和正控制組有顯 % 著差異的組別。攻擊劑量(Challengedose) =LD90 〇 附件1為圖2的彩色示意圖。 附件2為圖4的彩色示意圖。 29 201024414 【序列表】 <110>國立台灣大學❹ Figure 3 shows the detection of Chlorella vulgaris treated by different conditions by PCR (whether the first phantom body chromosome contains the transgenic gene. M: molecular weight target. n: negative control group without template. p: containing lng Transgenic Orthodontic m. Wild C. elegans chromosomes 1 to 11: Pseudococcal staining by gene transfer treatment. (4): Electroporation with ikv. (B): Electroporation at 2 kV. ® 4 _(4): After 60 days of culture on acacia medium, two of the transgenic algae strains (〇829A and 〇82 yang) can produce a ring of color around the sag. (8) Wild type or unstable reproduction The algae plant has no orange ring around it. (c): The algae plant with no colored ring around it will not produce red fluorescence under the glory microscope. (D): Algae plant with a colored ring around it (E): The algae plant with an orange ring around it can observe the red fluorescence under the fluorescence microscope. Figure 5 shows whether RT-PCR can detect the exogenous transcription of the rhodococcus after heat-induced treatment. Gene.Μ: molecular weight target. N: control group without template. p: positive control group containing lng transgenic gene. W: wild species Chromosome chromosomes. 1~4: Chromosome chromosomes processed by gene transfer. LF-LR: can be amplified into the introduction group of the coding region of the transgenic gene to know whether the exogenous gene is transgenic Transcription is carried out in Chlorella vulgaris. PF-LR: The promoter of the transgenic gene and the primer set of the coding region can be amplified to examine whether the experiment has been contaminated with DNA by the transgenic plastid. 28 201024414 Figure 6 shows the use of SDS -PAGE analysis of the total protein of C. elegans before and after heat-induced treatment, and Western blotting with appropriate antibodies. (A): Take 5 〇ml of lxlO7 cell/ml of S. cerevisiae to SDS- PAGE (12%) for the analysis of the protein of the genus Chlorella.] VI. Molecular weight standard. W: Total soluble protein of the wild species of Chlorella vulgaris. Ding: total soluble protein of the transgenic algae. Heat shock: 42. The culture is carried out for 16 hours. (B): Whether the exogenous protein can be expressed by the appropriate primary antibody, the position indicated by the arrow is the exogenous protein labeled by the antibody. Cyclic test of transgenic antimicrobial peptides After digestion, its antibacterial activity. Figure 8 shows the relationship between the number of days after injection of white spot virus and the mortality of grasshoppers in the oral vaccine infection test. Days after injection: days after white spot virus injection; cumulative mortality (8): accumulation of grasshoppers Mortality. The side of the line marked with a star-shaped singularity slightly different from the positive control group. Challengedose = LD90 〇 Annex 1 is the color diagram of Figure 2. Annex 2 is the color diagram of Figure 4. 29 201024414 [Sequence List] <110> National Taiwan University
<120>使擬球藻成為生物反應器之基因轉殖技術 <130> 0745-NTU-TW <160> 14 <170> Patent In version 3.4 ❿ <210> 1 <211> 520 <212> DNA <213>人工序列<120> Gene transfer technique for making Chlorella sp. as a bioreactor<130> 0745-NTU-TW <160> 14 <170> Patent In version 3.4 ❿ <210> 1 <211><212> DNA <213> artificial sequence
<220> <223〉 reiw/zmftii的熱休克蛋白70A基因之啟動子與j,5_二碌酸核嗣 糖羧化酶/加氧酶小次體2基因之啟動子的融合基因 <220> <221> misc_feature <222> (1)..(520) <400> 1 60 cggcggggag ctcgctga〇g cttgacatga ttggtgcgta tgtttgtato aagctacagg 1 ❹ 201024414 actgatttgg cgggctatga gggcgcggga agctctggaa gggccgcgat ggggcgcgcg gcgtccagaa ggcgccatac ggcccgctgg cggcacccat ccggtataaa agcccgcgac cccgaacggt gacctccact ttcagcgaca aacgagcact tatacatacg cgactattct gccgctatac ataaccactc agctagctta agatcccatc aagcttgcat gccgggcgcg ccagaaggag cgcagccaaa ccaggatgat gtttgatggg gtatttgagc acttgcaacc ^ cttatccgga agccccctgg cccacaaagg ctaggcgcca atgcaagcag ttcgcatgca gcccctggag cggtgccctc ctgataaacc ggccaggggg cctatgttct ttactttttt acaagagaag tcactcaaca tcttaaaatg gccaggtgag <210> 2 <211> 775 <212> DNA <213>人工序列 <220> <223>可表現紅螢光(DsRed)與牛乳鐵蛋白(LFB)之cDNA <220> <221> misc_feature <222> (1)..(775) 120 180 240 300 360 420 480 520 60 60<220><223> Reiw/zmftii fusion gene of heat shock protein 70A gene promoter and j,5-dihydro acid ribose carboxylase/oxygenase small body 2 gene promoter <; 220 > < 221 > misc_feature < 222 > (1) .. (520) < 400 > 1 60 cggcggggag ctcgctga〇g cttgacatga ttggtgcgta tgtttgtato aagctacagg 1 ❹ 201024414 actgatttgg cgggctatga gggcgcggga agctctggaa gggccgcgat ggggcgcgcg gcgtccagaa ggcgccatac ggcccgctgg cggcacccat ccggtataaa agcccgcgac cccgaacggt gacctccact ttcagcgaca aacgagcact tatacatacg cgactattct gccgctatac ataaccactc agctagctta agatcccatc aagcttgcat gccgggcgcg ccagaaggag cgcagccaaa ccaggatgat gtttgatggg gtatttgagc acttgcaacc ^ cttatccgga agccccctgg cccacaaagg ctaggcgcca atgcaagcag ttcgcatgca gcccctggag cggtgccctc ctgataaacc ggccaggggg cctatgttct ttactttttt acaagagaag tcactcaaca tcttaaaatg gccaggtgag < 210 > 2 < 211 > 775 < 212 > DNA <213>Artificial sequence <220><223> can express red fluorescent (DsRed) and bovine lactoferrin (LFB) cDNA <220><221> misc_feature <222> (1)..(775) 120 180 240 300 360 420 480 520 60 60
201024414 <400> 2 gctagcaccg gtcgccacca tgttcaaatg tcgtcgttgg caatggcgta tgaaaaaatt aggtgctcct tctattacat gtgtacgtcg tgctttcatg gcctcctccg agaacgtcat caccgagttc atgcgcttca aggtgcgcat ggagggcacc gtgaacggcc acgagttcga gatcgagggc gagggcgagg gccgccccta cgagggccac aacaccgtga agctgaaggt ^ gaccaagggc ggccccctgc ccttcgcctg ggacatcctg tccccccagt tccagtacgg ctccaaggtg tacgtgaagc accccgccga catccccgac tacaagaagc tgtccttccc cgagggcttc aagtgggagc gcgtgatgaa cttcgaggac ggcggcgtgg cgaccgtgac ccaggactcc tccctgcagg acggcigctt catctacaag gtgaagttca tcggcgtgaa cttcccctcc gacggccccg tgatgcagaa gaagaccatg ggctgggagg cctccaccga gcgcctgtac ccccgcgacg gcgtgctgaa gggcgagacc cacaaggccc tgaagctgaa ggacggcggc cactacctgg tggagttcaa gtccatctac atggccaaga agcccgtgca gctgcccggc tactactacg tggacgccaa gctggacatc acctcccaca acgaggacta caccatcgtg gagcagtacg agcgcaccga gggccgccac cacctgttcc tgtag 120 180 240 300 360 420 480 540 600 660 720 775 3 201024414 <210> 3 <211> 78 <212> DNA <213>人工序列 <220> <223>藻類密碼子最佳化後的LFBcDNA <220> 參 <221> misc_feature <222> (1)..(78) <400> 3 atgttcaaat gtcgtcgttg gcaatggcgt atgaaaaaat taggtgctcc ttctattaca tgtgtacgtc gtgctttc201024414 < 400 > 2 gctagcaccg gtcgccacca tgttcaaatg tcgtcgttgg caatggcgta tgaaaaaatt aggtgctcct tctattacat gtgtacgtcg tgctttcatg gcctcctccg agaacgtcat caccgagttc atgcgcttca aggtgcgcat ggagggcacc gtgaacggcc acgagttcga gatcgagggc gagggcgagg gccgccccta cgagggccac aacaccgtga agctgaaggt ^ gaccaagggc ggccccctgc ccttcgcctg ggacatcctg tccccccagt tccagtacgg ctccaaggtg tacgtgaagc accccgccga catccccgac tacaagaagc tgtccttccc cgagggcttc aagtgggagc gcgtgatgaa cttcgaggac ggcggcgtgg cgaccgtgac ccaggactcc tccctgcagg acggcigctt catctacaag gtgaagttca tcggcgtgaa cttcccctcc gacggccccg tgatgcagaa gaagaccatg ggctgggagg cctccaccga gcgcctgtac ccccgcgacg gcgtgctgaa gggcgagacc cacaaggccc tgaagctgaa ggacggcggc cactacctgg tggagttcaa gtccatctac atggccaaga agcccgtgca gctgcccggc tactactacg tggacgccaa gctggacatc acctcccaca acgaggacta caccatcgtg gagcagtacg agcgcaccga gggccgccac cacctgttcc tgtag 120 180 240 300 360 420 480 540 600 660 720 775 3 201024414 <210> 3 <211> 78 <212> DNA <213> Sequence <220><223> LFC cDNA after optimization of algae codons <220><221> misc_feature <222> (1)..(78) <400> 3 atgttcaaat gtcgtcgttg gcaatggcgt atgaaaaaat taggtgctcc Ttctattaca tgtgtacgtc gtgctttc
<210> 4 <211> 49 <212> DNA <213>人工序列 <220> <223> PCR前置引子 <220> 49 201024414 <221> m i sc_b i nd i ng <222> (1)..(49) <400> 4 <210> <211> <212> <213> gctagcaccg gtcgccacca tgttcaaatg tcgtcgttgg caatggcgt 5<210> 4 <211> 49 <212> DNA <213> artificial sequence <220><223> PCR pre-priming <220> 49 201024414 <221> mi sc_b i nd i ng < ;222> (1)..(49) <400> 4 <210><211><212><213> gctagcaccg gtcgccacca tgttcaaatg tcgtcgttgg caatggcgt 5
39 DNA <220> <223> 人工序列 PCR前置引子 參 <220> <221 > <222> <400> misc_binding (1)..(39) 5 gcaatggcgt atgaaaaaat taggtgctcc ttctattac 39 <210> 6 <211> 39 <212> DNA <213> 人工序列 5 201024414 <220> <223> PCR前置引子 <220> <221> m i sc_b i nd i ng <222> (1)..(39) <400> 6 cttctattac atgtgtacgt cgtgctttca tggcctcct 3939 DNA <220><223> Artificial sequence PCR pre-introduction<220><221><222><400> misc_binding (1)..(39) 5 gcaatggcgt atgaaaaaat taggtgctcc ttctattac 39 < ;210> 6 <211> 39 <212> DNA <213> Artificial sequence 5 201024414 <220><223> PCR pre-introduction <220><221> mi sc_b i nd i ng <222> (1)..(39) <400> 6 cttctattac atgtgtacgt cgtgctttca tggcctcct 39
<210> 7 <211> 33 <212> DNA <213>人工序列 <220> <223> PCR反置引子<210> 7 <211> 33 <212> DNA <213> artificial sequence <220><223> PCR inverted primer
<220> <221> misc_binding <222> (1)..(33) <400> 7 atttgtgatg ctattgcttt atttgtaacc att 33 6 201024414 <210> 8 <211> 615 <212> DNA <213> 白點病病毒(white spot syndrome bacu丨ovirus)<220><221> misc_binding <222> (1)..(33) <400> 7 atttgtgatg ctattgcttt atttgtaacc att 33 6 201024414 <210> 8 <211> 615 <212> DNA <213> white spot syndrome bacu丨ovirus
<220> <221 >基因 <222> (1)..(615) <400> 8 atggatcttt ctttcactct ttcggtcgtg gctgtattta ttgtgatttt taggtatcac acagacaata tcgagacaaa catggatgaa ggatcaggct acttcaagat gactgatgtg aagatccgca atggaaagtc tgatgcacag actcccgtgg agggccgagc actcgaagtg acattcaagg tgtggaacaa cacatcaaga ccaaagatta acccatcaaa ggcctttgtc gtctctattg atgaggatga agttggcacc tcggccatcc tcgecatcac tgctgtgatt aacactgtga ccaagaccat cgaaacccac aacctccgca ttcctgtgac tgctgaggtt tcctttgaca gcgacacctt gggcaaaatc atgaaggaag aagatgcgga tcttgtcatc actgtggggc agaatctcac ctttgaggga aagatcaaca tcactggtat gcagatggtg ggtagctcca acacctcctc cttcaccccc tttgtgtgtg gtaccacctt tggcgcacca 60 120 180 240 300 360 420 480 540 7 201024414 attgcagcta ccgccggtgg aaatcttttc gacatgtacg tgcacgtcac ctactctggc actgagaccg agtaa 600 615≪ <; 220 & gt 221 > gene < 222 > (1) .. (615) < 400 > 8 atggatcttt ctttcactct ttcggtcgtg gctgtattta ttgtgatttt taggtatcac acagacaata tcgagacaaa catggatgaa ggatcaggct acttcaagat gactgatgtg aagatccgca atggaaagtc tgatgcacag actcccgtgg agggccgagc actcgaagtg acattcaagg tgtggaacaa cacatcaaga ccaaagatta acccatcaaa ggcctttgtc gtctctattg atgaggatga agttggcacc tcggccatcc tcgecatcac tgctgtgatt aacactgtga ccaagaccat cgaaacccac aacctccgca ttcctgtgac tgctgaggtt tcctttgaca gcgacacctt gggcaaaatc atgaaggaag aagatgcgga tcttgtcatc actgtggggc agaatctcac ctttgaggga aagatcaaca tcactggtat gcagatggtg ggtagctcca acacctcctc cttcaccccc tttgtgtgtg gtaccacctt tggcgcacca 60 120 180 240 300 360 420 480 540 7 201024414 attgcagcta ccgccggtgg aaatcttttc gacatgtacg tgcacgtcac ctactctggc actgagaccg agtaa 600 615
<210> 9 <211> 615 <212> DNA <213> 黃緒鯛(Acanthopagrus latus) <220> <221 >基因 <222> (1)..(615) <400> 9 atggacagag tggtgctcat gctgtcggtg ctgtctctgg gcgtctcctc tcagccgatc acagacggcc agcgtctgtt ctccatcgct gtcagcagag ttcaacacct ccacctgctc ❹ gctcagagac tcttctctga ctttgagagc tctctgcaga ctgaggagca acgacagctc aacaaaatct tcctgcagga tttctgtaac tctgattaca tcatcagccc catcgacaag cacgagacac agcgcagctc agtgttgaag ctgctgtcta tctcctatcg attggtcgag tcttgggagt tccccagtcg ttctctggct ggcggttctg ctccaaggaa ccagatttca cccaaactgt ctgagctgaa gacaggcatc catctcctga tcagggccaa tgaggatgga 60 120 180 240 300 360 8 420 201024414 gcagagctct agtccgggca gacatgcaca aactgcaccc tccctgatag ccgacgagtc aggtggagac tgtag ctccgccctc cagctggctc cttatggaga ctactaccaa gctgagacga acctacgaac tacttgcctg ctacctgaca gtggcaaaat gtagactctc tttcaaaaaa tccagaggcc 480 540 600 615<210> 9 <211> 615 <212> DNA <213> Huang Xuan (Acanthopagrus latus) <220><221> gene <222> (1).. (615) < 400 > 9 atggacagag tggtgctcat gctgtcggtg ctgtctctgg gcgtctcctc tcagccgatc acagacggcc agcgtctgtt ctccatcgct gtcagcagag ttcaacacct ccacctgctc ❹ gctcagagac tcttctctga ctttgagagc tctctgcaga ctgaggagca acgacagctc aacaaaatct tcctgcagga tttctgtaac tctgattaca tcatcagccc catcgacaag cacgagacac agcgcagctc agtgttgaag ctgctgtcta tctcctatcg attggtcgag tcttgggagt tccccagtcg ttctctggct ggcggttctg ctccaaggaa ccagatttca cccaaactgt ctgagctgaa gacaggcatc catctcctga tcagggccaa tgaggatgga 60 120 180 240 300 。 。 。 。 。 。 。 。 。
❹ <210> 10 <211> 26 <212> DNA <213>人工序列 <220> <223>轉殖基因的專一性引子 <220> <221> miscj)inding <222> (1)..(26) <400> 10 26 cctcctccga gaacgtcatc accgag <210> 11 <211> 21 9 201024414 <212> DNA <213>人工序列 <220> <223>轉殖基因的專一性引子 <220> <221> m i sc_b i nd i ng <222> (1)..(21) ❹ <400> 11 cctcggtgcg ctcgtactgc t 21 <210> <211> <212> <213> <220> <223>❹ <210> 10 <211> 26 <212> DNA <213>Artificial sequence <220><223> Recombination gene specificity primer <220><221> miscj)inding <222> (1)..(26) <400> 10 26 cctcctccga gaacgtcatc accgag <210> 11 <211> 21 9 201024414 <212> DNA <213> artificial sequence <220><223> The specificity primer of the transgenic gene <220><221> mi sc_b i nd i ng <222> (1)..(21) ❹ <400> 11 cctcggtgcg ctcgtactgc t 21 <210><211><212><213><220><223>
12 26 DNA 人工序列 參 可偵測內生性18S rRNA基因的引子 <220> <221 > <222> <400> misc_binding (1)..(26) 12 10 201024414 26 gcggaggaaa agaactaacc aggatt <210> 13 <211> 19 <212> DNA <213>人工序列 <220>12 26 DNA artificial sequence reference primer for detecting endogenous 18S rRNA gene <220><221><222><400> misc_binding (1)..(26) 12 10 201024414 26 gcggaggaaa agaactaacc aggatt < ;210> 13 <211> 19 <212> DNA <213>Artificial Sequence<220>
<223>可偵測內生性18S rRNA基因的引子 <220> <221> misc_binding <222> (1)..(19) <400> 13 19 aacgccatgg cacaaccgc <210> 14 <211> 18 <212> DNA <213>人工序列 <220> <223>寡聚脫氧胸苷酸(OligodT)引子 11 201024414 <220> <221> misc_binding <222> (1)..(18) <400> 14 tttttttttt tttttttt 18<223> The primer for detecting the endogenous 18S rRNA gene <220><221> misc_binding <222> (1)..(19) <400> 13 19 aacgccatgg cacaaccgc <210> 14 < 211 > 18 <212> DNA <213> artificial sequence <220><223> oligodeoxythymidine (OligodT) primer 11 201024414 <220><221> misc_binding <222> (1) ..(18) <400> 14 tttttttttt tttttttt 18
1212
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW97151401A TW201024414A (en) | 2008-12-30 | 2008-12-30 | Nucleic acid for use in algae and use thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW97151401A TW201024414A (en) | 2008-12-30 | 2008-12-30 | Nucleic acid for use in algae and use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW201024414A true TW201024414A (en) | 2010-07-01 |
Family
ID=44852075
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW97151401A TW201024414A (en) | 2008-12-30 | 2008-12-30 | Nucleic acid for use in algae and use thereof |
Country Status (1)
| Country | Link |
|---|---|
| TW (1) | TW201024414A (en) |
-
2008
- 2008-12-30 TW TW97151401A patent/TW201024414A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Li et al. | Transgenic microalgae as a non-antibiotic bactericide producer to defend against bacterial pathogen infection in the fish digestive tract | |
| CN104754954B (en) | Transgenic microalgae and their use for oral delivery of proteins | |
| Hallmann | Algal transgenics and biotechnology | |
| Chen et al. | Conditional production of a functional fish growth hormone in the transgenic line of nannochloropsis oculata (Eustigmatophyceae) 1 | |
| Hallmann | Algae biotechnology–green cell-factories on the rise | |
| US20080107652A1 (en) | Methods and compositions for control of disease in aquaculture | |
| US20220338453A1 (en) | Engineered catfish and uses thereof | |
| CN101182360B (en) | A fusion protein with antibacterial function and its application | |
| Peng et al. | Using an improved Tol2 transposon system to produce transgenic zebrafish with epinecidin-1 which enhanced resistance to bacterial infection | |
| CN106029091B (en) | Algal-based edible vaccines | |
| Wang et al. | Using bait microalga as an oral delivery vehicle of antimicrobial peptide for controlling Vibrio infection in mussels | |
| CN103387966A (en) | Pichia pastoris expressing Penicillium albicans lipase efficiently heterologously and its enzyme-producing medium | |
| CN110106175B (en) | A kind of dsRNA and its application in pest control | |
| US20110014708A1 (en) | Nucleic acid for use in algae and use thereof | |
| TW201024414A (en) | Nucleic acid for use in algae and use thereof | |
| CN104593362B (en) | DNA sequence for encoding myrmecia incisa caleosin (MiClo) and application thereof | |
| CN110452290A (en) | From the application in vegetables biological and ecological methods to prevent plant disease, pests, and erosion of exciton albumen and its encoding gene of broom Thamnidium fungi | |
| CN101164431A (en) | Feed additive with antibiotic function and application | |
| CN103333898A (en) | Constructing method and application of transgenic chlamydomonas reinhardtii for expressing epinephelus antibacterial peptide piscidin | |
| CN101940180B (en) | Sugpo prawn larva breeding method | |
| US20140170181A1 (en) | Vaccine against white spot syndrome virus | |
| TW201035310A (en) | Foreign protein expression system in microalgae and method for expressing foreign protein in microalgae | |
| Huddy | Development of a transformation protocol and cell culture system for the commercially important species of red macroalga, Gracilaria gracilis | |
| Li et al. | Feeding the transgenic microalgae containing bovine lactoferricin enhances the | |
| CN117778451A (en) | Method for immunizing tilapia against vibrio alginolytic disease by transfecting OmpU genetically engineered microalgae |